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One of the challenging issues in the development of crystallization processes for 
active pharmaceutical ingredients (APIs) is to obtain the desired polymorphic form of the 
product. Though chemically identical, polymorphs are structurally different crystalline 
solids. Consequently, they exhibit different physico-chemical properties which can 
impact both the processability and performance of the drug. Unfortunately, crystallization 
process may go out of control even with a small variation in the process conditions such 
as cooling rate, feed conditions etc. which can impact the polymorphic outcome. Given 
such a situation, a deeper understanding about the fundamental aspects of polymorphism 
and crystallization mechanisms governing the polymorph formation and transformation is 
necessary. Only then a robust process can be developed to isolate the desired crystal 
form. Having said this, the objective of this work is to understand the polymorphism and 
crystallization aspects of an anti-diabetic drug, Tolbutamide (TB), to develop a robust 
crystallization process for the isolation of the desired form for this drug.        
In the first part, the structural and stability features of various TB polymorphs 
(Forms (IL, IH) and II–IV) were characterized using various analytical techniques. It has 
been found that the conformational flexibility of the TB molecule and strong hydrogen 
bonding ability of secondary amide via carbonyl and sulfonyl groups facilitate TB to 
crystallize into different polymorphic forms. The rich torsional freedom available for the 
terminal alkyl chain mainly assists TB molecule to adopt various conformers and 
crystalline packing arrangements. By elucidating the crystal structures of various 
polymorphic forms of TB, the present work resolves several discrepancies in the 
published data on structural features of the polymorphs of this API. The relative 




thermodynamic relationships of TB polymorphic pairs were evaluated and the stability 
domains were elucidated in the form of a schematic energy-temperature diagram. Form II 
is found to be the thermodynamically stable polymorph from absolute zero to ~353 K and 
beyond which Form IH is the stable polymorph. The discrepancies in the literature related 
to the relative stability of TB polymorphs at ambient conditions are highlighted and 
partially resolved.   
 In the second part, using Quality by Design (QbD) based strategy, a robust cooling 
crystallization process was developed to achieve the desired polymorph, Form (IL, IH), of 
TB. In applying QbD, crystallization process characterization studies were carried out 
using process analytical technology (PAT). A polymorphic transformation study of TB 
polymorphs Form IL→ Form II suggests that the primary nucleation of the stable Form II 
is the controlling step for the transformation. Metastable zone width (MZW) 
measurements indicate that the cooling rate and solute concentration has a strong 
influence on the nucleation energy barrier and can be used as manipulators for achieving 
different TB polymorphs. Finally, using this information, a crystallization design space 
was derived in terms of metastability of Form (IL, IH) and a crystallization batch process 
was successfully operated within the design space to achieve the desired form.  
This work also demonstrates the application of two PATs, ATR-FTIR combined 
with orthogonal partial least squares (OPLS), a robust chemometric method and Raman 
combined with a dynamic principal component analysis (PCA) based multivariate 
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Simulation 
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CSP   Computational Crystal Structure Prediction 
DSC   Differential Scanning Calorimetry 
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1.1. Background and Motivation  
 
Solution crystallization is the most utilized technique in pharmaceutical industry for 
high purity separation (Variankaval et al., 2008). Being simple, flexible and energy 
efficient, it offers many advantages over other separation techniques. The main targets of 
crystallization are to produce crystals with high chemical purity and desired physical 
properties such as size, shape and crystal structure. However, despite the long history and 
widespread application, crystallization is not a well understood phenomena and suffers 
from poor control characteristics. It becomes more complex when multiple crystal forms 
(polymorphs) are produced. Therefore, crystallization process development and its 
control are regarded as challenging. 
1.1.1. Crystal Polymorphism and Its Importance  
Recently, there is a significant interest in crystal polymorphism in pharmaceutical 
industry (Henck et al., 1997; Rouhi, 2003). It is the ability of a molecule to crystallize in 
more than one crystal structure (also referred to as form or polymorph). It is a widespread 
phenomenon among drug molecules and more prevalent when the molecule has binding 
sites for solvent molecules in the crystal lattice leading to pseudopolymorphs or solvates 
(Bingham et al., 2001). Literature values suggest that 51% of the drug substances are 
truly polymorphic (Storey et al., 2004). If solvates are included this value goes up to 
87%. In fact, according to McCrone (1965), polymorphism is not limited to a few but 
exists in every compound and the number of polymorphs known for a given compound is 
proportional to the amount of time and money spent in investigating the molecule. This is 




well supported by many reports on the discovery of new polymorphs either 
serendipitously (Rubin-Preminger and Bernstein, 2005; Vishweshwar et al., 2005; Day et 
al., 2006; Rafilovich and Bernstein, 2006) or by expansive search e.g. high throughput 
screening (Almarsson et al., 2003; Morissette et al., 2003), using high pressure (Fabbiani 
et al., 2007), using supercritical fluids (Bettini et al., 2009) etc.      
The practical importance of this phenomenon is based on the fact that the different 
solid forms may have different physical and chemical properties including chemical 
reactivity, solubility, stability, mechanical properties etc (Huang and Tong, 2004). The 
differences in surface and mechanical properties can influence the downstream 
processing of drug substances into drug products i.e. filtration, drying, handling in 
powder form, formulation activities etc. On the other hand, differences in thermodynamic 
properties like solubility may have profound effect on the bioavailability1
Hence, characterization of all possible polymorphs and identifying the desired form 
is a crucial step in drug development process. But, even after a thorough search for 
polymorphs, there are many instances where new polymorphs have been discovered later 
in development (
 of the drug by 
affecting its dissolution characteristics. This is critical particularly for low solubility 
compounds and any variations can lead to severe effects in patients. Another 
consideration is the physical stability of the drug substance which depends on the crystal 
form and unstable forms can spontaneously transform to more stable form over time 
during any stage of the drug manufacturing.   
Chemburkar et al., 2000; Desikan et al., 2005; Prashad et al., 2010). This 
can lead to serious manufacturing issues. Once new polymorphs appear, the previously 
                                                 
1 is a measurement of the extent of a therapeutically active drug that reaches the systemic circulation and is 
available at the site of action 




known polymorphs may disappear (Dunitz and Bernstein, 1995; Henck et al., 2001) or 
become irreproducible (Bauer et al., 2001). Besides this, the late discovery of new 
polymorphs can also lead to patent litigations (Bernstein, 2002). This unpredictable 
nature of polymorphism clearly demonstrates our lack of understanding in this 
phenomenon. Hence, from both the customers and regulatory agencies point of view, 
such as Food and Drug Administration (FDA), understanding polymorphism to improve 
the control over solid-state of drug substances remains a major theoretical, technological 
and economical issue. 
1.1.2. Crystallization Process Development for a Specific Polymorph 
When a desired polymorph is chosen for drug manufacturing, it is vital to have a 
robust crystallization process which consistently produces that form. To this aim, it is 
essential to understand the factors which govern the polymorph formation and its 
transformation. In crystallization, once the solution enters into the metastable state (non-
equilibrium), the crystallization kinetic pathways will determine which form will 
crystallize and for how long it can survive (Bernstein, 2002). To achieve ultimate control 
over polymorphic crystallization, manipulation of these pathways to direct the process 
towards the desired polymorph is required. Over the last decade, many such strategies 
have been developed (Llinas and Goodman, 2008). Some important ones are using tailor-
made additives to stabilize the desired form (Davey et al., 1997; He et al., 2001), use of 
solvents to promote the nucleation of the desired polymorph (Blagden and Davey, 2003; 
Weissbuch et al., 2005; Kitamura et al., 2006) and control of nucleation using templates 
(Mitchell et al., 2001; Dressler and Mastai, 2007).  However, these methods are system 
specific and requires good understanding in molecular aspects of crystallization where 




our knowledge is extremely poor and therefore limits the level of process control (Schuth, 
2001; Towler and Taylor, 2007).  
The other approach which has currently been practiced by industry is based on 
Quality by Design (QbD) which is motivated by the new recent initiatives from FDA to 
adopt modern technology to develop more science-based processes (McKenzie et al., 
2006). The underlying premise of QbD is that the quality cannot be tested into products, 
instead it should be built by process design. Bohlin et al. (2009) have discussed the 
concept of QbD, its benefits and application to develop robust crystallization processes 
with several examples. Some potential benefits of developing processes in QbD approach 
are the regulatory flexibility i.e. manufacturers are allowed to make changes to process, 
greater robustness and easy trouble shooting.   
Essentially, QbD involves experimental screening of input and process parameters 
to determine a design space2
Yu, 2008
 (operating region where the crystallization of the desired 
polymorph is guaranteed) and with appropriate controls installed to operate within the 
control space (upper and/or lower limits of operating parameters between which the 
process is controlled) to produce the desired form ( ). To this aim, in situ 
analytical technologies, usually referred to as PATs (process analytical technologies), 
play a crucial role in process characterization, analysis and control (Yu et al., 2004; 
Variankaval et al., 2008). FDA also strongly recommends the liberal use of PAT to assist 
the implementation of QbD. Some of the potential benefits of PATs are: improved 
process understanding (Howard et al., 2009; Chen et al., 2009), faster and focused 
process development (Starbuck et al., 2002; Birch et al., 2005; Desikan et al., 2005; 
                                                 
2 ‘Design space’ is also referred to as “crystallization space” or “occurrence domain” or “polymorphic 
window” 




Saranteas et al., 2005; Muller et al., 2006; Zhou et al., 2009), online assessment of 
polymorphic quality (Ono et al., 2004; Scholl et al., 2006; Caillet et al., 2007; Borissova 
et al., 2009; Klimakow et al., 2010) and implementation of advanced control strategies 
(Abu Bakar et al., 2009; Kee et al., 2009a; Kee et al., 2009b).  
However, recent reviews on applications of PATs in crystallization suggest that 
there still exists a significant gap between research and industrial PAT implementations 
(Yu et al., 2004; Fevotte, 2007; Wu et al., 2007; Yu et al., 2007). Technology, system 
reliability and the necessity for chemometric calibration exercise limiting its progression 
to industrial environments (Barrett et al., 2010). Therefore, developing and implementing 
PAT to improve the control over industrial crystallization processes is one of the most 
important research topics currently emerging in this area.    
1.2. Research Objectives and Approach 
The main objective of this work is to gain fundamental understanding about various 
aspects of crystal polymorphism and crystallization mechanisms governing the 
polymorph formation and transformation to develop a process to achieve the desired 
polymorph. Tolbutamide (TB), an anti-diabetic drug, was chosen as the model 
compound. The thesis work will comprise the following milestones:  
 Determine the structural origin of polymorphism in TB by elucidating the internal 
arrangement of TB molecule in the crystal lattice of various polymorphs. To 
achieve this, X-ray diffraction experiments were conducted and crystal structures 
were solved. As a complementary technique, spectroscopic measurements were 
also performed.  




 Establish the relative stabilities of TB polymorphs. To achieve this, thermal 
analysis, solubility measurements and slurry experiments were performed to 
understand the stability relationships between TB polymorphs. Finally, a 
schematic energy- temperature diagram was constructed to elucidate the stability 
domains.  
 Design a robust crystallization process for the isolation of the desired polymorph 
in a QbD paradigm. To achieve this, two PATs, ATR-FTIR and Raman 
spectroscopy were employed. Solubility curves, metastable zone widths and 
polymorph transformation kinetics were characterized. Finally, a crystallization 
design space was derived and a crystallization batch process was successfully 
demonstrated while operating in the design space to achieve the desired 
polymorph. 
1.3. Dissertation Outline  
 Chapter 2 introduces the fundamentals of crystal polymorphism, polymorph 
characterization techniques and crystallization aspects of polymorphs.  
 Chapter 3 introduces the model system (Tolbutamide) and its related previous work 
and describes the experimental techniques used for the characterization of crystal 
polymorphism of this system. 
 Chapter 4 reports the results on structural and thermodynamic features of TB 
polymorphs. Three new crystal structures of TB were solved and the thermodynamics 
were detailed in the form of an energy-temperature diagram. By reporting these results, 
several discrepancies in the published data on the structural and thermodynamic aspects 




of polymorphs of this API have been resolved. It has also been highlighted the influence 
of anisotropic thermal motion of TB molecule on PXRD patterns of TB polymorphs. 
 Chapter 5 introduces PAT and QbD based crystallization process development and 
describes crystallization PATs used in the present work. Two novel chemometric 
methods which have been coupled with PATs were also introduced. The experimental 
setup, instrumentation and experimental methods used were outlined. 
 Chapter 6 reports the results on crystallization process development for the 
isolation of the desired polymorph of TB. Results obtained on crystallization 
characterization studies including solubility curves, transformation kinetics and 
metastable zone width were presented and discussed. Based on these results, a 
crystallization design space was derived and a crystallization batch was demonstrated 
while operating in the design space. This chapter also demonstrates the application of two 
PAT tools, ATR-FTIR combined with OPLS (PCA) and Raman combined with MSPM, 
in crystallization processes.      
 Chapter 7 gives a summary of the significant outcomes of this study together with 
the scope for future work. 
   





Crystallization and Polymorphism 
 
 
2.1. Introduction  
 
Crystallization is a molecular assembly process by which a group of random 
molecules in a fluid come together to form an ordered structure which we call a crystal. 
As an esteemed purification technique, crystallization relies on the stringent structural 
requirement of the growing crystal which only accommodate similar molecular segments 
to exclude impurities. However, the internal structure adopted by the crystal is an 
important property which must be carefully controlled to achieve a desired product 
quality. A holistic understanding of crystallization mechanisms, influence of operating 
conditions and their relation with structural outcome is, therefore, a prerequisite for the 
design and development of a robust crystallization process for the consistent production 
of the desired crystal form. This chapter mainly aims at introducing fundamentals of 
crystal polymorphism, polymorph characterization and crystallization aspects of 
polymorphic compounds.  
2.2. Structural Aspects of Polymorphism 
Polymorphism (Greek: poly = many, morph = form) is the ability of a substance 
to exist as two or more crystalline phases that have different arrangements and/or 
conformations of the molecules in the crystal lattice (Grant, 1999). Mitscherlich (1820) is 
the first to discover this phenomenon in relation to inorganic materials. Wohler and 
Liebig (1832) discovered the first example of polymorphism in organic material, 
benzamide. Subsequently, Ostwald (1897) concluded that almost every substance could 
exist in two or more solid phases provided the experimental conditions are suitable. The 
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development of solid state chemistry during the twentieth century has confirmed and 
exemplified this statement and a large number of polymorphic compounds have been 
noted and catalogued (Kuhnert-Brandstatter, 1971; Borka and Haleblian, 1990; Borka, 
1991).  
2.2.1. Crystalline State: Fundamentals 
A crystal is a highly ordered solid constructed by identical structural units, termed 
unit cells, each of which contains all the structural features and symmetry elements and is 
repeated regularly in three-dimensional space. The dimensions of the unit cell are 
characterized by six quantities; three axial lengths (𝑎, 𝑏, 𝑐) and three interaxial angles 
(𝛼,𝛽, 𝛾). Each unit cell can be classified by one of the seven three-dimensional 
coordinate systems, which are the seven primitive crystal systems.  
The internal symmetry of the unit cell (lattice) is expressed by crystallographers 
as a space group which is a combination of symmetry operations (14 Bravais lattices and 
32 point groups) that enables a complete crystal structure to be generated from a single 
(or group of) molecule(s) called asymmetric unit (𝑍′). There are 230 space groups which 
describe all the possible ways in which identical objects can be packed in an infinite 
lattice. However, only certain space groups are seen frequently, whereas others have 
never been found in crystals. According to cambridge structural database (CSD), ~76% 
of all organic and organometallic compounds crystallize in only five space groups – 
P21/c, P212121, P1�, P21, and C2/c. 
2.2.2. Structural Origin of Polymorphism 
As polymorphs are the different crystal structures adopted by a given molecule, 
they possess different unit cell dimensions, lattice parameters, molecular conformation 
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etc. However, these differences can vary from subtle to huge depending upon the 
structural origin of polymorphism. Structural differences between the polymorphs 
originate through two mechanisms, namely, packing polymorphism and conformational 
polymorphism. Packing polymorphism is a mechanism by which molecules that are 
conformationally relatively rigid can be packed into different three-dimensional 
structures, e.g. p-nitrophenol (Kulkarni et al., 1998) and sulfathiazole (Blagden et al., 
1998). Conformational polymorphism is a mechanism by which conformationally 
flexible molecules can fold into different shapes that can pack into different crystal 
structures, e.g. anti-viral agent virazole (Prusiner and Sundaralingam, 1976). 
In general, the differences in packing arrangements invariably affect the 
molecular geometry and, conversely, the differences in molecular geometry cause the 
molecules to pack differently. As a result, most examples of polymorphism in organic 
crystals have a mixed origin and exhibit differences in both the conformation and packing 
arrangement of the constituent molecules, e.g. ROY (Yu et al., 2000), ritonavir (Bauer et 
al., 2001). 
2.3. Thermodynamics of Polymorphs  
 
In crystalline solids, because of the long range order, the molecules sit together 
more tightly and pack more efficiently thereby greatly reduce their intermolecular 
distances and occupy the lowest energy level on the potential energy curve (Grant, 1999). 
Thermodynamically, polymorphs can be described as energetically closely spaced 
minima on the potential energy curve. The differences in energy between the polymorphs 
arise from the variations in non-covalent interactions between the constituent molecules 
in the crystal lattice, such as hydrogen bonds, van der Waals forces, electrostatic 
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interactions etc. The polymorph with the lowest energy is the thermodynamically most 
stable form and polymorph with the higher energy will sooner or later convert to the most 
stable form. Kinetically, however, the conversion rate is variable and depends on many 
factors such as activation energy, impurities etc (Giron, 2005; Cui, 2007). 
2.3.1. Polymorphic Transformations 
 
Based on the structural criteria, Buerger (1951) has classified the phase 
transformations in solids into two types. If the two structures involved in the 
transformation are largely different, the transition may proceed via a reconstructive 
mechanism, i.e. disintegration of the unstable form and reconstruction of the new stable 
form.  This type of transformation requires higher activation energy and therefore would 
proceed in a sluggish fashion. Presence of solvent (solvent mediated transformation) or 
melt (melt mediated transformation) can facilitate the transformation by acting as a 
catalyst (Sato, 1993).  
On the other hand, if the two structures are similar, the transition may proceed via 
a displacive mechanism, i.e. molecules of the unstable structure are displaced to yield the 
new structure in such a way that the nearest neighbor interactions are preserved and only 
the second neighbors will change. Such transitions require low activation energy and 
therefore would proceed very rapidly as equivalent as the transmission of heat (Dunitz, 
1995). 
2.3.2. Thermodynamic Relationships 
 
Application of Gibbs phase rule to a polymorphic system derives that at constant 
pressure, two polymorphic forms can coexist in equilibrium only at one temperature, 
termed transition temperature (𝑇𝑡). In other words, the free energy (𝐺) of the two 
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polymorphs becomes equal at this temperature. Consequently, polymorphic systems can 
be divided into two categories – monotropic and enantiotropic. These relationships are 
illustrated in Fig. 2.1, where two polymorphs, Forms I and II are exemplified. 
 
Figure 2.1 Gibbs energy profiles of dimorphic systems (a) and (b) enantiotropic, and (c) 
monotropic. (𝑇𝑓𝑢𝑠𝐼 and 𝑇𝑓𝑢𝑠𝐼𝐼 are the melting temperatures of Forms I and II respectively). 
 
Fig. 2.1(a) and (b) show the enantiotropic case in which 𝑇𝑡 lies below the melting 
point of the lower melting polymorph. Therefore, the stability order reverses below and 
above 𝑇𝑡. However, this does not necessarily mean that the phase transformation to a 
more stable form is also reversible at 𝑇𝑡. As a result, enantiotropic systems are further 
divided into two types – kinetically irreversible and kinetically reversible. In kinetically 
irreversible systems, the transformation (reconstructive type) is kinetically hindered until 
it gains sufficient thermal energy to cross the energy barrier. The temperature at which 
transformation occurs is normally referred to as the experimental or kinetic transition 
temperature. In such case, both forms are experimentally accessible below and above 𝑇𝑡. 
On the other hand, in kinetically reversible systems, a reversible solid phase 
transformation (displacive type) occurs at 𝑇𝑡  and both forms are mutually exclusive. As a 
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Fig. 2.1b, the dotted line represents the virtual states of Forms I and II that cannot be 
obtained experimentally.  
In monotropic systems (Fig. 2.1c), 𝑇𝑡 lies above the melting points of the 
polymorphs and no change in the stability order with respect to temperature i.e. 𝐺𝐼𝐼 < 𝐺𝐼 
at all temperatures. However, a phase transformation still may occur from the less stable 
to the more stable polymorph at any temperature. 
2.3.3. Energy-Temperature Diagrams  
 
Energy-temperature (E-T) diagrams were first introduced in crystallography by 
Buerger (1951) and subsequently, Burger and Ramberger (1979) and Grunenberg et al. 
(1996) further developed these diagrams to extend the applications to polymorphic 
systems. They are often used to present the relative stabilities of polymorphs and phase 
transformations in a compact form and provide a graphical solution to derive 
thermodynamic relationships. Threlfall (2009) has recently provided a comprehensive 
guide on experimental work and methodology involved in constructing these diagrams.   
Typical E-T diagrams for a dimorphic system, Forms I and II, are shown in Fig. 2.2, 
for both enantiotropic and monotropic systems. They are semi schematic diagrams 
showing the relative positions and points of intersection of enthalpy (𝐻) and free energy 
(𝐺) curves of polymorphs at constant pressure, against temperature (𝑇) ranging from 
absolute zero to melting temperature (𝑇𝑓𝑢𝑠). Two additional isobars, the 𝐻𝐿𝐼𝑄 and 𝐺𝐿𝐼𝑄 
curves are also shown to represent the enthalpy and free energy of liquid. The theoretical 
foundation for the construction of these diagrams is based on three important 
observations related to a crystalline solid: 
 
 




Figure 2.2 Schematic Energy-Temperature diagrams for a dimorphic system Forms I and II (a) 
monotropy and (b) enantiotropy. 𝑇𝑓𝑢𝑠 : Melting temperature, 𝑇𝑡 : Transition temperature, 𝐻 : 
Enthalpy, 𝐺 : Free energy, ∆𝑓𝑢𝑠𝐻 : Enthalpy of fusion, ∆𝐻 : Enthalpy of transition, LIQ : Liquid. 
 
 The molar heat capacity (𝐶𝑝) increases with increase in temperature and defines a 
positive slope for the 𝐻 isobar. 
 Based on third law of thermodynamics, entropy (𝑆) is shown as increasing with 
temperature starting from zero at absolute zero. This fixes as 𝐺 = 𝐻 at absolute 
zero. 
 As a result of first and second laws of thermodynamics, the 𝐺 isobar is shown as 
decreasing with increasing temperature. 
To predict the thermodynamic relations between the polymorphs, several empirical 
rules have been developed and popularly known as Burger and Ramberger’s rules 
(Burger and Ramberger, 1979). Three important rules which proved useful are: 
Heat of Transition Rule. This rule states that if the phase transformation observed at the 
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we can conclude that the two polymorphs are enantiotropically related. If it is 
exothermic, then there is no 𝑇𝑡 below this temperature. This can occur either when the 
two polymorphs are monotropically related or when the two polymorphs are 
enantiotropically related with 𝑇𝑡 lying above the kinetic transition temperature. This rule 
makes correct predictions in 99% of cases (Lohani and Grant, 2006).   
Heat of Fusion Rule. This rule states that if the higher melting polymorph has the lower 
heat of fusion, then the two polymorphs are enantiotropic, otherwise they are monotropic. 
Often, phase transformations are too slow to be observed before melting and in such 
cases, heat of fusion rule may be applied. This rule is based on the assumption that the 
heat of transition can be approximated by the difference between the heats of fusion of 
the polymorphs (Hess’s law of heat summation3
Giron, 1995
). Exceptions to this rule may arise when 
the enthalpy curves of the two polymorphs diverge significantly, or when the difference 
between the melting points of the two polymorphs is larger than ~30 K ( ). 
Density Rule. This rule states that if a polymorph has highest density than others at room 
temperature, then it may be assumed that at absolute zero this form is the most stable. 
This rule assumes that most stable form has closest packing i.e. shorter intermolecular 
distances, thus lowest free energy. However, in some cases, directional hydrogen bonds 
dominate and stabilize the polymorph with lower density (Robertson and Ubbelohde, 
1938; Haisa et al., 1974).  
To construct the E-T diagrams for a compound which crystallizes in 𝑛 
polymorphs, 2𝑛 parameters are needed. These include the melting temperatures (𝑇𝑓𝑢𝑠) 
and heat of fusions (∆𝑓𝑢𝑠𝐻) of all the polymorphs. Melting temperatures fix the stability 
                                                 
3 Hess’s law of heat summation: the enthalpy change accompanying a transformation is the same whether 
the process occurs in one or many steps and total enthalpy change is the summation of all steps. 
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order of polymorphs at higher temperatures whereas the fusion data fix the stability order 
at absolute zero. The melting points and fusion data are usually measured calorimetrically 
(refer to section 2.5.3).  
2.3.4. Determination of Transition Temperature  
There are several methods currently available to experimentally determine or 
estimate the transition temperature (𝑇𝑡) (Higuchi et al., 1963; Yu, 1995; Gu and Grant, 
2001; Hu et al., 2007). The most commonly used method is the measurement of 
solubilities of the polymorphs (solubility extrapolation method). This method is based on 
the fundamental relationship between solubility and free energy of the polymorph.  
Solubility expresses the maximum amount of material that can be dissolved in a 
known amount of solvent at a given temperature and pressure (Bennema et al., 2008). 
Thermodynamically, this corresponds to the balance of free energy (𝐺) of solid phase 
against that of the solute in the solution phase. Therefore, at solid-liquid equilibrium,                                  𝐺𝑠𝑜𝑙𝑖𝑑 = 𝐺𝑠𝑜𝑙𝑢𝑡𝑒 = 𝐺0 + 𝑅𝑇𝑙𝑛 (𝑎𝑠𝑜𝑙𝑢𝑡𝑒)                                              (2.2) 
where 𝐺0 is the free energy of pure substance, 𝑅 the gas constant and 𝑎𝑠𝑜𝑙𝑢𝑡𝑒 the solute 
activity. With 𝑎𝑠𝑜𝑙𝑢𝑡𝑒 = 𝛾𝑠𝑜𝑙𝑢𝑡𝑒𝐶𝑒𝑞, with 𝛾𝑠𝑜𝑙𝑢𝑡𝑒 being the activity coefficient of solute 
and 𝐶𝑒𝑞 the solubility, Eq. 2.2 can be rewritten as:                                  𝐺𝑠𝑜𝑙𝑖𝑑 = 𝐺𝑠𝑜𝑙𝑢𝑡𝑒 = 𝐺0 + 𝑅𝑇𝑙𝑛 (𝛾𝑠𝑜𝑙𝑢𝑡𝑒𝐶𝑒𝑞)                                       (2.3) 
This important result shows that the free energy curve of solids can be followed by 
measuring the solubilities at different temperatures. Thus, transition temperature can be 
accurately located at which solubilities of two polymorphs crossover each other. For 
practical purposes, vant Hoff’s plots i.e. 𝑙𝑛(𝐶𝑒𝑞) versus (1/𝑇) are used. The solubility 
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curve is then linearized and can be interpolated and extrapolated (Beiny and Mullin, 
1987). 
2.4. Polymorph Screening - the Search for Polymorphs 
The search for polymorphs of a given compound can be dealt with two different 
approaches; experimental and computational (Guillory, 1997; Hilfiker et al., 2006).  
Experimental approach mainly depends on the primary nucleation kinetics of the solid 
phase (Aaltonen et al., 2009; Mangin et al., 2009). Primary nucleation mainly depends on 
three parameters; solvent (which determines the interfacial energy γ  between nucleus and 
solution), supersaturation (𝜎) and temperature (for more details, refer to section 2.7.2). 
Therefore, the strategy is to vary these parameters to cover a large range of experimental 
space to explore polymorphism.  
The most commonly used experimental techniques are crystallization from 
solution (cooling, evaporation, anti-solvent and slurry conversion) and crystallization 
from neat compound (melt crystallization, sublimation and thermal treatment). For 
solvent based methods, the selection of right set of solvents is important. Ideally, solvents 
as diverse as possible in properties including polarity, hydrogen bond acceptor/donor 
propensity, dielectric constant etc. should be selected. In this regard, some recent work on 
solvent diversity can greatly facilitate rational and rapid selection of solvents (Gu et al., 
2004; Alleso et al., 2008). To accelerate the screening process, high-throughput (HT) 
methods which utilizes an automated robotic system capable of performing thousands of 
crystallizations has been developed (Morissette et al., 2004; Alvarez et al., 2009). Such 
new technologies not only accelerate screening but also provide more insights into the 
relationships between crystallization outputs and inputs (McCabe, 2010). 
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Computational approach is based on molecular modeling and global optimization 
techniques which energetically evaluate all possible packing arrangements of a given 
molecule in all reasonable space groups with all possible conformations (Lewis et al., 
2003; Gavezzotti, 2005; Young and Ando, 2007). The resulting crystal structures of low 
lattice energy are regarded as the potential polymorphs. This approach has been able to 
generate the previously known polymorphs of molecules such as progesterone (Payne et 
al., 1999). However, computational methods generally overestimate the propensity of 
polymorphism and outputs too many structures in which many are never observed 
(Davey, 2003; Price, 2008). Further reduction in predicted structures requires inclusion of 
kinetic effects as well as more accurate thermodynamic models (Price, 2004; Price, 
2008). Nevertheless, analysis of predicted structures provides useful information such as 
common hydrogen bonding motifs etc. which can be used in designing experimental 
strategies to crystallize specific predicted packing motifs (Cross et al., 2003; Florence et 
al., 2006; Hulme et al., 2007).  
2.5. Polymorph Characterization Techniques 
 
Solid-state characterization is a crucial step in drug development to understand 
the solid-state properties to provide the drug in a solid form that has optimum 
performance in various stages of drug manufacturing. It also renders useful information 
in devising methods for analysis and control of the desired form (Byrn et al., 1994; 
Newman and Byrn, 2003). Several analytical techniques are commonly used for 
polymorph characterization. A brief discussion of some commonly used methods is 
presented here. 
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2.5.1. X-ray Crystallography 
X-ray crystallographic techniques are concerned with the structural aspects of 
polymorphs and provide the clearest indication of the existence of polymorphism. These 
techniques are based on the remarkable discovery made by Laue (1912) that crystals can 
diffract X-rays. However, Bragg (1913) was the first to exploit this finding to deduce a 
simple relationship, now known as the Bragg’s law― 𝑛𝜆 = 2𝑑 sin𝜃  in which 𝑑 is the 
distance between the crystal planes, 𝜃 is the angle of diffraction of the X-rays, 𝜆 is the 
wavelength of X-rays and 𝑛 is an integer. When Bragg’s law is satisfied at a crystal 
plane, X-rays are reflected from the plane and the intensity of the radiation is maximized. 
With a single crystal brought into all orientations with respect to the X-ray beam, a 
unique set of Bragg’s reflections representing the internal structure can be obtained. 
Together with 2𝜃 positions of diffraction maxima and their vector parameters (magnitude 
and phase) in the lattice space, the complete crystal structure which includes the unit cell, 
lattice parameters and positions of all the atoms in the crystal lattice can be determined 
(Glusker et al., 1994). 
 These techniques can be performed with either single crystal or crystalline powder. 
Single crystal X-ray diffractometry (SCXRD) gives the most precise structural 
information for polymorphs and provides greatest understanding related to molecular 
conformation, packing differences and hydrogen bonding pattern etc. However, the 
stringent requirement of high quality single crystals of suitable size (0.05–0.1mm) and 
longer data processing time (1–2 days) preclude it from being used on a routine basis for 
characterization (Datta and Grant, 2004). Special procedures are often required to prepare 
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satisfactory crystals such as slow cooling, solvent diffusion, vapor diffusion, seeding etc 
(Etter et al., 1986; Etter and Baures, 1988; Vandersluis and Kroon, 1989).  
Powder X-ray diffractometry (PXRD) is the other and the most utilized technique 
for the study of polycrystalline materials. It is fast, flexible and well suited for the routine 
characterization of polymorphs. In principle, it captures the same information as obtained 
by SCXRD, but with three dimensional data compressed into one dimension, thus 
yielding a unique powder pattern for each polymorph (Brittain, 1999). Moreover, recent 
advances in this field have made possible, although challenging, complete structural 
solution from the powder pattern (refer to section 2.6).  
One common problem with PXRD is the preferred orientation effects from 
crystals which are non-isometric such as plates, needles etc. These may result in 
inconsistent patterns which are difficult to interpret (Pecharsky and Zavalij, 2003). 
Grinding may significantly improve the results, but this is risky as applying energy may 
induce polymorphic transformation.      
2.5.2. Solid-State Spectroscopy 
Solid-state spectroscopy is another category of techniques complementary to 
diffraction techniques. Infrared (IR), Raman and solid-state nuclear magnetic resonance 
(SS-NMR) are the most prominent in this category. The basic principles and applications 
of spectroscopy in crystal polymorphism are summarized in a number of reviews 
(Threlfall, 1995; Brittain, 1997; Bugay, 2001). Typically, the purpose of spectroscopic 
investigation in polymorphic systems is to gather information about the underlying 
structural aspects that give rise to the observed crystallographic differences. This analysis 
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is particularly useful when crystallographic data is not available (Brittain et al., 1993; 
Raghavan et al., 1993; Raghavan et al., 1994).  
IR and Raman Spectroscopy. IR and Raman are based on transitions between molecular 
vibrational states upon interaction with electromagnetic radiation (Chalmers and Dent, 
2006). In IR spectroscopy, radiation passing through the sample is selectively absorbed 
by molecular vibrations of the same frequency as incident radiation to transit to a higher 
vibrational state. In Raman spectroscopy, a high energy monochromatic radiation (laser) 
is incident upon a sample to affect the electron cloud of a molecular bond and makes it to 
oscillate from its equilibrium position to an unstable excited state and back. For a small 
portion of incident light, inelastic relaxation occurs; the electron relaxes to a higher or 
lower level than what it started from, leading to stokes or anti-stokes scattering with 
energy displacements (Raman shift) corresponding to the molecular vibrational transition 
frequencies. 
While in IR and Raman spectrum, the band position i.e. absorption frequency in 
IR and wavenumber shift  (∆ cm-1) in Raman depends on the molecular vibrational 
frequency, the intensity depends on how effectively the photon energy is transferred to 
the molecule (Colthup et al., 1990). The mechanism by which photon energy transfers 
differs in both techniques; in IR, it is associated with a change in dipole moment where as 
in Raman, it is associated with a change in polarizability. As a result, these two 
techniques complement one another and IR inactive vibrations can be strong in Raman 
spectra and vice versa.   
When applied to polymorphic systems, Raman has some important advantages 
over IR (Findlay and Bugay, 1998; Vankeirsbilck et al., 2002). (1) Raman spectra are 
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collected readily in the 40–400 cm-1 spectral region (typically unavailable on an IR 
spectrometer) where crystal lattice vibrations occur (Carteret et al., 2009). (2) No sample 
preparation is required (3) Glass is transparent to excitation and emitted radiation and 
gives no interfering bands therefore, spectra can be obtained without removing the 
sample from the specimen tube (Threlfall, 1995). (3) Insensitive to moisture effects 
owing to the weak scattering nature of water and hence much easier to study aqueous 
based systems.  
However, a major problem with Raman measurements is the fluorescence 
(intrinsic or caused by impurities) of the sample which masks the Raman bands. 
However, in most cases, this can be avoided by increasing the laser wavelength at the 
expense of loss in signal intensity (Romero-Torres et al., 2009).  
SS-NMR spectroscopy. SS-NMR is based on the differences in energy absorption by the 
observed nuclei in a magnetic field (Bugay, 1993). Most SS-NMR spectra of 
pharmaceutical solids are acquired using cross polarization with magic-angle spinning 
(CP-MAS), most often with 13C nuclei detections (Tishmack et al., 2003; Geppi et al., 
2008). CP-MAS is a double resonance technique with cross polarization (CP) facilitating 
magnetization transfer from abundant nuclei (usually 1H) to dilute nuclei (e.g. 13C, 15N). 
1H to 13C CP results in a four-fold increase in the sensitivity of 13C nuclei and reduction 
in relaxation delay between successive pulse sequences (Brittain, 1997). Magic-angle 
spinning (MAS) serves to reduce or eliminate the inhomogeneous broadening effects of 
chemical shift anisotropy (CSA), such that only the isotropic chemical shift is observed. 
These two techniques, coupled with high power 1H decoupling can enable acquisition of 
SS-NMR spectra that approach the resolution attainable in solution NMR experiments. 
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  SS-NMR is well-suited for the study of polymorphism because small changes in 
conformation and/or local electronic structure can cause analogous nuclei to resonate at 
different frequencies and observable differences in chemical shift (Apperley et al., 1999; 
Harris, 2006). When compared to IR and Raman, it can provide some ‘extra’ information 
on crystallographic aspects such as number of molecules in the asymmetric unit in a unit 
cell (Doherty and York, 1988; Harris et al., 1997), molecular dynamics and short-range 
order (Gao, 1998; Masuda et al., 2006). In fact, NMR-crystallography is a growing 
subject area which focuses on the complete crystal structure solution from SS-NMR data 
alone (Harris, 2004; Brouwer et al., 2005).  
2.5.3. Thermal Techniques 
Thermal techniques are those in which a property of the analyte is determined as a 
function of an externally applied temperature. In the context of polymorphism, they play 
a crucial role in elucidating the energetic aspects of polymorphs including 
thermodynamic relationships, E-T diagrams etc. Applications of thermal techniques in 
solid-state characterization are extensively reviewed in the literature (Barnes et al., 1993; 
Giron, 1995; Giron, 2002; Giron et al., 2004; Craig, 2006).  
Under this category, the most widely used technique is differential scanning 
calorimetry (DSC). Conceptually, DSC measures the change in enthalpy of the analyte 
(the heat differential between the sample and a reference) as a function of temperature. 
Intrinsically, the measured quantity is the heat capacity (𝑑𝐻 𝑑𝑇� ) and as the analyte 
undergoes any thermal event, the total heat capacity of the system changes due to the 
latent heat associated with it. The commonly observed thermal events in a DSC 
thermogram are melting (endotherm), crystallization (exotherm), phase transition 
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(endotherm or exotherm) and glass transition (change of heat capacity without either 
absorption or emission of heat) etc. The area under the curve for a thermal event will be 
proportional to the energy involved in the process; hence, by suitable calibration with 
standards, properties like heat of fusion and heat of transition can be quantitatively 
determined (Clas et al., 1999). 
In addition to DSC, there are a few other thermal methods which have been 
proven useful for the study of polymorphism. Thermogravimetry (TG) measures the 
change in mass of the analyte upon heating a sample is useful in the study of 
pseudopolymorphs (Giron, 1995). Solution calorimetry which measures the heat of 
solution as the solid dissolves in an excess of solvent is an elegant method for detecting 
and characterizing polymorphic transitions (Canotilho et al., 1997; Royall and Gaisford, 
2005). High-speed DSC which gives the flexibility of using high heating rates was 
proven useful in studying metastable forms (McGregor and Bines, 2008). 
Thermal methods are often combined with X-ray diffraction or spectroscopic 
techniques to get deeper insight into the physical and chemical processes which occur 
upon heating. Variable temperature X-ray diffractometry (VT-XRD) is the commonly 
used technique in which controlled environment allows the study of polymorphic 
transformations as a function of temperature (Asnani et al., 2009). TG-mass spectroscopy 
(TG-MS) and TG-IR are the two combined techniques also proved useful in the study of 
pseudopolymorphs to identify the volatile compound (Materazzi and Curini, 2001; 
Materazzi and Curini, 2001). 
 
 




Microscopic techniques are preliminary tools which can be used to identify 
crystal forms based on the differences in morphological and optical properties 
(birefringence, indices of refraction, dispersion colour etc.). They are divided into two 
types; light microscopy (LM) that probe features on the order of a micron or larger and 
electron microscopy (EM) that study materials at sub-micron level.  
LM combined with fusion methods (hot stage microscopy (HSM)) is a powerful 
technique in which a sample is heated or cooled to observe any physical or chemical 
change e.g. melting, crystallization, polymorphic transformation, desolvation etc. 
Kuhnert-Brandstatter and his co-authors used HSM alone in his extensive search for new 
polymorphs/solvates of pharmaceutical compounds and to determine their stability 
relationships (Kuhnert-Brandstatter, 1971). LM can also be interfaced with spectroscopy, 
for example, hot stage IR microscopy, has been used to characterize polymorphic purity 
and conversions (Giron, 2002). 
Under EM, two important techniques are scanning electron microscopy (SEM) 
and atomic force microscopy (AFM). In polymorphism research, SEM is commonly used 
to obtain high resolution images of crystals to characterize the habit and surface features 
etc (Borka, 1991). AFM has been used mainly to study the crystal growth mechanisms 
(Bauer et al., 2001).  
2.6. Crystal Structure Solution from Powder X-ray Diffraction Data  
 
The ab initio crystal structure determination of molecular materials from PXRD 
data is a rapidly expanding field, and has grown substantially in the last ten years (Harris 
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et al., 2002). This section highlights some of the difficulties associated with structure 
solution method and recent advances in this field to overcome them.     
2.6.1. Why are Powders more difficult than Single Crystals?  
As mentioned before, in the case of powders, the diffraction data is compressed 
into one dimension. As a consequence, the Bragg’s reflections from different crystal 
planes are averaged over directions and there is a considerable overlap of peaks in PXRD 
pattern. This obscures the information on intensities of individual diffraction maxima 
which are required for the construction of the underlying crystal structure (Harris et al., 
2001). Moreover, space group determination using powders is more ambiguous because 
the regions in the pattern, which should be free of peaks because of systematic absences, 
are often overlaid with peaks of other reflections (Datta and Grant, 2004). In addition to 
these, a more general problem is the preferred orientation of crystals which can affect the 
relative intensities of peaks and hinders the correct solution of the pattern. 
2.6.2. Powder Indexing – the Crucial Step  
Two key steps in structure solution from diffraction data are indexing and 
structure solution. Indexing involves the determination of unit cell parameters and space 
group by analyzing the peak positions in the powder pattern. Structure solution focuses 
on the determination of atomic co-ordinates from the peak intensities. Clearly, if the 
correct unit cell is found at the indexing stage, it is possible to proceed further to solve 
the structure. The three indexing programs most commonly in use are ITO (Visser, 1969), 
TREOR (Werner et al., 1985) and DICVOL (Boultif and Louer, 1991) which typically 
require the first 20–25 well resolved peaks. Using this input, a number of possible 
solutions are generated and ranked according to their figure of merit (Jenkins and 
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Gilfrich, 1992). However, the existing algorithms frequently fail due to the occurrence of 
peak overlap and the correct unit cell is difficult to distinguish from the large number of 
incorrect solutions with similar figures of merit.   
2.6.3. Recent Advances  
Despite these difficulties, significant progress has been made in this area mainly 
due to the advances in diffraction instrumentation and computational power. On the 
instrumental side, improvements in resolution, particularly with synchrotron X-ray 
sources, have lead to dramatic reductions in peak overlap and allowed highly accurate 
measurements of peak positions and intensities (Hastings et al., 1984; Cheetham and 
Wilkinson, 1991). This has given the opportunity to use single crystal structure solution 
techniques (e.g. direct methods or Patterson methods) to powder diffraction data 
(Altomare et al., 2004) and much success has been reported. However, these techniques 
which are referred to as traditional methods have certain intrinsic limitations. The 
extraction of accurate intensities from PXRD pattern, which is a crucial requirement for 
success of this approach, is not always possible and limits the complexity of structures 
that can be solved by traditional methods (Knudsen et al., 1998).  
Because of the above limitation, much recent interest has focused on the 
development of new methods for solving crystal structures from PXRD data. Direct 
space approach is such a method which is based on global optimization methods (Harris 
et al., 1994). In this approach, instead of extracting the intensity data from PXRD pattern, 
the molecular fragments within the unit cell are directly manipulated to vary the position, 
orientation and conformation to generate trial structures independent of the experimental 
PXRD data. The suitability of each trial structure is assessed by direct comparison 
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between the PXRD pattern calculated for the trial structure and the experimental PXRD 
pattern. This comparison is quantified via a least-squares fit parameter Rwp, known as 
weighted powder profile R-factor. This process is equivalent to exploring a hyper surface Rwp(Г) to find the global minimum, where Г represents the set of variables that define 
the structure (structural degrees of freedom). A number of different optimization 
algorithms have been applied as part of direct space strategy including Monte Carlo 
simulated annealing (MC/SA), genetic algorithm techniques etc. 
On the other hand, with the emergence of direct space strategies and scoring high 
success in obtaining crystal structures from PXRD pattern, powder indexing has emerged 
as a new important bottleneck. Improved versions of the existing algorithms such as X-
cell (Neumann, 2003), N-TREOR (Altomare et al., 2000) were developed to address 
various issues typically encountered in indexing such as  contamination, strong peak 
overlap, zero-point shift etc. Kariuki et al. (1999) described a new approach aiming at 
indexing PXRD data by using a whole profile fitting technique and a global optimization 
method based on genetic algorithm.  
Recently, Harris and Cheung (2004) have provided a tutorial review on 
methodology for structure determination from PXRD pattern using direct space strategies 
with many examples ranging from simple to complex molecules. Stephenson (2000) has 
examined the application of this method to solve structures of true/pseudo polymorphs of 
pharmaceutical molecules and highlighted the role of complementary spectroscopic 
techniques in assessing the correct solution. 
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2.7. Crystallization Fundamentals 
Essentially, crystallization is a kinetic process occurs in a boundary fixed by 
thermodynamics. In crystallization of polymorphs, each crystal form is associated with a 
different kinetic path and a thermodynamic boundary. To achieve ultimate control over 
polymorphic crystallization, it is essential to understand the factors which govern the 
kinetics and thermodynamics of polymorphs.    
Supersaturation. Supersaturation (𝜎), a dimensionless parameter, is commonly used to 
quantify the thermodynamic driving force for crystallization. The generic definition of 
supersaturation is, the difference of chemical potential of a molecule in its supersaturated 
state (𝜇𝑠𝑠), and in its equilibrium state (𝜇𝑒𝑞). In terms of measurable quantities, 
supersaturation can be defined using solute activity (𝑎𝑠𝑜𝑙𝑢𝑡𝑒) or concentration (𝐶) as 
(Davey and Garside, 2000): 
ln𝜎 = (𝜇𝑠𝑠 − 𝜇𝑒𝑞) 𝑘𝑇� = 𝑙𝑛 �𝑎𝑠𝑜𝑙𝑢𝑡𝑒𝑠𝑠𝑎𝑠𝑜𝑙𝑢𝑡𝑒𝑒𝑞 � ≈ 𝑙𝑛 �𝐶𝑠𝑠𝐶𝑒𝑞�                                            (2.2) 
If 𝜎 < 1, the solution is undersaturated and the existing crystals will dissolve; if 
𝜎 > 1, the solution is supersaturated and crystals can nucleate and grow; and if 𝜎 = 1, 
the solution is at equilibrium. Supersaturation can be achieved in several ways – for 
example cooling a solution, or by solvent evaporation, or by addition of an anti-solvent 
etc. 
Nucleation. The formation of crystals in a supersaturated solution begins with 
‘nucleation’ which is a kinetic process of molecular aggregation and formation of 
nanoscopically small molecular clusters of the new crystalline phase (Kashchiev and van 
Rosmalen, 2003). Nucleation can be either primary, which occurs in the absence of 
crystalline surfaces, or secondary, which requires the presence of a crystal surface for 
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further generation of crystal nuclei. Primary nucleation can be divided into two types; 
primary homogeneous which occurs in the pure bulk solution and primary heterogeneous 
which is catalyzed by surface or interface of different composition than the crystallizing 
solute. These mechanisms are thoroughly discussed by Mullin (1993) and Zettlemoyer 
(1969).  
 The general behavior of supersaturated solutions is well described by classical 
nucleation theory (CNT) based on the work of Gibbs (1948) and Volmer (1939). This 
theory assumes that the formation of nuclei arises from a sequence of bimolecular 
reactions of solute molecules. The thermodynamic description of this process defines the 
free energy change (∆𝐺) for formation of a nucleus of size 𝑛, as the balance between the 
energy gained by formation of bulk phase (−𝑛𝑘𝑇𝑙𝑛 𝜎) and the energy required to form 
new surface area (γ𝐴𝑐). The equation can be written as: 
𝐺𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 − 𝐺𝑐𝑙𝑢𝑠𝑡𝑒𝑟 = ∆𝐺 = −𝑛𝑘𝑇𝑙𝑛 𝜎 +  γ𝐴𝑐                                           (2.3) 
where γ is the interfacial tension of the cluster-solution interface, 𝑘 is the Boltzmann’s 
constant, and 𝐴𝑐 is the surface area of the cluster. Therefore, as the cluster size increases  
∆𝐺 goes through a maximum at a critical size 𝑛∗, above which the ∆𝐺 decreases 
continuously and growth becomes energetically favorable, resulting in the formation of 
crystal nuclei. Assuming spherical clusters, the homogeneous nucleation rate  𝐽, the 
number of supernuclei (𝑛 > 𝑛∗) generated in the solution of constant supersaturation per unit 
time per unit volume, can be written in an Arrhenius-type expression: 
𝐽 = 𝐴 exp �−∆𝐺∗
𝑘𝑇
� = 𝑁𝑜𝑣  exp� −16πυ2γ33(𝑘𝑇)3(𝑙𝑛 σ)2�                                     (2.4) 
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where ∆𝐺∗ is the critical free energy change, 𝐴 is the preexponential factor, 𝑁𝑜 is the 
number of solute molecules in a unit volume of solution, 𝑣 is the frequency of atomic or 
molecular transport at the nucleus-liquid interface, and υ is the molecular volume. 
One of the key outcomes of this theory is the concept of kinetic barrier for 
nucleation. Thus, even though 𝜎 > 1 nucleation does not occur unless 𝜎 exceeds certain 
threshold value which is called the metastable zone width (MZW) (the maximum 
allowable supersaturation before solid phase separation occurs). Eq. 2.4 also suggests that 
the nucleation kinetics and the kinetic barrier depend not only on supersaturation 𝜎 but 
also on kinetic parameters such as molecular transport (hidden in preexponential factor 𝐴) 
and solid-liquid interfacial tension etc.  
Crystal Growth. Once the nuclei are formed and exceed the critical size, they become 
crystals which grow around the nuclei as the solute molecules deposit from the 
supersaturated solution. The rate of crystal growth 𝐺𝑐, the incremental mass of solute 
deposited per unit surface area per unit time is generally expressed as the following 
empirical equation (Garside et al., 2002):  
𝐺𝑐 = 𝑘𝑔𝜎𝑔                                                                          (2.5)    
where 𝜎 is the supersaturation, 𝑘𝑔 is an empirical coefficient depending on temperature 
and agitation, 𝑔 is a numerical known as growth rate order. 
 Crystal growth involves two consecutive and independent processes: transport of 
the solute molecules from the bulk of the solution to the surface of the crystal and 
incorporation of the incoming molecules into the crystal lattice. Therefore, crystal growth 
kinetics depends on both external factors (supersaturation, temperature, solvent, 
impurities, and hydrodynamics) and internal factors (structure, crystal defects). The rate 
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limiting step may be one or the other depending on the growth conditions. The crystal 
growth and rate controlling mechanisms are discussed in detail by Nyvlt et al. (1985) and 
Mullin (1993). 
2.8. Polymorphic Crystallization 
Let us consider a monotropically related dimorphic system of Forms I and II. Fig. 
2.3, is a schematic representation of the solubility curves of the two solid phases with 
Form II being less soluble i.e. more stable phase. Let us suppose we prepare a saturated 
solution with respect to Form II which corresponds to point A in Fig. 2.3. When it is 
cooled to point B, the solution becomes supersaturated with respect to both Forms I and 
II, however, crystals will not nucleate because the activation energy for nucleation (∆𝐺) 
is too high. As the process cools further, the supersaturation level increases and ∆𝐺 
decreases and finally reaches the MZW where spontaneous nucleation of crystals occur 
(point C). However, the interesting question here is which polymorph will nucleate at 
point C.  
Ostwald (1897) who systematically studied many polymorphic systems observed 
that a chemical system does not directly tend towards equilibrium but rather towards the 
closest metastable state. Therefore, according to his rule, the metastable Form I is always 
expected to nucleate prior to the more stable Form II. Though there are many examples 
that support this rule, there are also many exceptions. Later, Etter (1991) based on CNT 
proposed that, in a polymorphic system, there may exist several types of aggregates or 
clusters in solution resembling the structure of matured crystal forms which can compete 
for molecules. The polymorph which favored to crystallize is the one that nucleates the 
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Figure 2.3 Schematic solubility-temperature diagram for a cooling crystallization process for a 
dimorphic system Forms I and II. A: Saturated solution with respect to Form II, B: Metastable 
solution supersaturated with respect to both Forms I and II, C: Metastable zone width, D: 
Solubility of Form I, E: Solubility of Form II. 
 
1. If all the kinetic parameters are similar for both Forms I and II, nucleation rate 
will increase by increasing the supersaturation. This favors the condition (𝐽𝐼𝐼 > 𝐽𝐼) 
leads to nucleation of more stable Form II. 
2. At constant supersaturation, increase in molecular transport favors the condition 
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3. At constant supersaturation, decrease in interfacial energy (γ) favors the condition 
(𝐽𝐼 > 𝐽𝐼𝐼). Because, it has been proven that γ decreases with decreasing heat of 
dissolution and increasing value of solubility, both generally favor the metastable 
forms (Sangwal, 1989). 
Though CNT successfully predicts the general behavior of nucleation, its applications 
in polymorphism are very limited because of its implicit assumptions (Oxtoby, 1998). 
Moreover, it does not capture the contribution from structural factors such as solute-
solvent interactions, therefore, it cannot provide any information on the structure of 
aggregates and the pathways leading the solution to solid crystal (Schuth, 2001). If the 
structure of aggregates could be identified and related to structure in the final solid form, 
then a greater amount of control over the structural outcome of the crystallization might 
be achieved. A much recent work on nucleation both from simulations and experiments 
reveal that crystals obtained from solution are often not formed via the much simplified 
classical pathways but by much more complex routes in which specific intermolecular 
interactions play an important role (Anwar and Boateng, 1998; Vekilov, 2004; Davey et 
al., 2006). These studies suggest that our understanding on nucleation is very limited and 
prediction of polymorphic outcome is only possible if we fully understand the structural 
aspects of nucleation.  
However, in Fig. 2.3, at point C, if we suppose that experimental conditions 
favored the nucleation of metastable Form I. Then, crystallization continues further by 
the growth of Form I crystals. During this, solution concentration drops as solute 
molecules transfer from the liquid phase to the growing crystals until equilibrium is 
reached at point D, which is the solubility of Form I. However, at this point, the solution 
Chapter 2                                                                        Crystallization and Polymorphism 
 
 35 
is still supersaturated with respect to Form II and ultimately, Form I will have to 
transform to Form II by a process which is described below. 
2.9. Solvent Mediated Polymorphic Transformations (SMPT) 
In crystallization, a metastable form can transform to the more stable form via 
solvent mediated polymorphic transformation (SMPT) in which the solvent molecules 
facilitate the molecular rearrangement and crystal growth. The basic phenomenon 
involved in SMPT is well understood and expressed as a three step process (Cardew and 
Davey, 1985). 
 
Figure 2.4 Solute concentration (C) and polymorph fraction (P) Vs time profiles during a 
polymorphic transformation in solution, CeqI and CeqII are the solubilities of Forms I and II, (a) 
General solute concentration profile and (b) Transformation is controlled by growth of the stable 
Form II (c) Transformation is controlled by dissolution of the metastable Form I (Cardew and 
Davey, 1985; Mangin et al., 2009). 
 
1. Primary nucleation of the stable phase. This is the trigger for the transformation 
process and it can be homogeneous or heterogeneous (Croker and Hodnett, 2010).  
2. Dissolution of the metastable phase. As the nuclei of the stable phase grow, the 
solution concentration drops below the solubility of metastable phase. The 
metastable crystals thus dissolve producing supersaturation for the continued 
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3. Growth of the stable phase. This step simultaneously occurs with the step 2 and 
dissolution-growth process continues until all of the metastable crystals disappear. 
The growth of stable form continues further and finally transformation ends when 
solubility of stable form is reached. 
Depending on both the properties of solute and solvent, (1) or (2) or (3) can be the 
slowest step. When step (1) is rate controlling, any factor that affects nucleation kinetics 
(see Eq. 2.4) will determine the overall kinetics. When step (2) or (3) is controlling, the 
factors which can influence the solute mass transfer such as particle size, agitation etc. 
will determine the overall kinetics.  
Experimentally, transformation kinetics can be characterized by a combination of 
measurements of solid phase composition and solute concentration with respect to time 
(Davey et al., 1986). Fig. 2.4a shows the general behavior of solute concentration during 
a transformation process. It indicates that there exists a plateau concentration between the 
solubility of two forms as a result of the balance between kinetics of dissolution and 
growth. Based on the position of the plateau, two extreme cases are possible. (1) The 
consumption of solute by growth is slower than the production of solute by dissolution, 
and the plateau is located in a “high” position, in the vicinity of the solubility of the 
metastable polymorph (see Fig. 2.4b). Therefore, the nucleation and growth mechanism 
of the stable polymorph limits the transformation and thus is the rate-controlling step. 
There are many examples in the literature for this type of transformation: L-glutamic acid 
α→β in water (Kitamura, 1989), glycine α→γ in water (Yang et al., 2008), irbesartan 
Form A → Form B in water (Garcia et al., 2002), taltireline α→β transformation in water 
(Maruyama et al., 1999), carbamazepine anhydrate → hydrate transformation in 
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ethanol/water solution (Qu et al., 2006), citric acid anhydrate → monohydrate 
transformation in water (Caillet et al., 2006), sulfamerazine Form I → Form II in various 
solvents (Gu et al., 2001). (2) The concentration plateau is just above the solubility of the 
stable polymorph (see Fig. 2.4c). The dissolution mechanism of the metastable phase 
limits the transformation and is thus the rate-controlling step. To our knowledge, only 
one example available in the literature: glycine β→α in ethanol/water solution (Ferrari et 
al., 2003).  
2.10. Closing Remarks 
 Crystal structure is an important property which needs to be carefully controlled 
during crystallization to achieve the desired product quality. A thorough understanding of 
fundamentals of crystal polymorphism and the crystallization mechanisms which govern 
the polymorph formation and transformation is a prerequisite for the design and control 
of a robust crystallization process for the isolation of desired polymorph. 





Experimental – Materials, Methods and Analytics 
 
 
In this chapter, experimental methods used for polymorph characterization of the 
model compound are presented. In addition, the computational procedure for the structure 
determination from PXRD pattern is also described. 










Figure 3.1 Chemical diagram of Tolbutamide (TB) with several rotational degrees of freedom (τ 
= torsional angle). 
 
Sulfonylurea compounds are considered as an important class of therapeutical 
agents in medicinal chemistry for their hypoglycemic activity (Patlak, 2002). 
Tolbutamide (1-Butyl-3-(4-methylphenylsulfonyl) urea, TB) is a first generation oral anti-
diabetic drug that belongs to this class. It is used in the treatment of non-insulin 
dependent (type II) diabetes as an adjunct to diet control. It controls the blood glucose 
levels by stimulating the pancreas for secretion of insulin. TB tablets are marketed under 
the brand name Orinase®. The chemical structure of TB (Fig. 3.1) shows that apart from 
the rigid benzene ring, it has seven bonds that can rotate freely along the alkyl chain. Due 
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to this flexibility, one can expect this molecule to crystallize into different polymorphic 
structures. 
3.1.1. Previous Work 
The first study on polymorphism of TB was reported in the extensive study 
carried out by Kuhnert-Brandstatter and Wunsch (1969) on polymorphism and drugs 
using hot stage microscopy. The existence of three polymorphic forms with melting 
points of 127 °C, 117 °C and 106 °C were reported. Subsequently, the system was 
studied by Simmons et al. (1972) who reported two polymorphic forms which were 
prepared by crystallization experiments and named them as Forms A and B. Later, 
Burger (1975) further investigated the polymorphism of this drug and was able to prepare 
four polymorphic forms (Forms I–IV). He claimed that Forms I and III were identical 
with Simmon's Forms A and B. The stability order was estimated to be Form I > Form 
III > Form II > Form IV with Form I being the most stable form at ambient conditions. 
Later, Rowe and Anderson (1984) further examined the stability order of Forms I and III 
and observed that Form I readily transforms to Form III in solution at ambient 
conditions. Hence, they claimed that Form I is less stable than Form III. 
In CSD, two crystal structures of TB, reference codes ZZZPUS01 (Nirmala and 
Gowda, 1981) and ZZZPUS02 (Donaldson et al., 1981), are indexed and both correspond 
to Form I. Form I crystallizes in the orthorhombic, Pna21 space group (𝑍 = 4; a = 20.23 
Å, b = 7.83 Å, c = 9.09 Å). The unit cell data for Form III has been reported but without 
atomic co-ordinates (Leary et al., 1981). Form III crystallizes in the monoclinic, P21 
space group (𝑍 = 2; a = 8.11 Å, b = 8.96 Å, c = 10.19 Å, β = 101°). More recently, 
Kimura et al. (1999) further characterized Burger’s Forms II and IV using various 
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physical methods. The unit cell data of Form II was determined and deposited in CSD 
(refcode: ZZZPUS03) without atomic co-ordinates. This form crystallizes in the 
monoclinic, P21/n space group (𝑍 = 4, a = 11.81 Å, b = 9.06 Å, c = 13.98 Å, β = 104.5°). 
From the previous studies, it is evident that TB can crystallize in at least four 
polymorphic forms which have been well characterized by various techniques. However, 
there is some confusion about the stability order of TB polymorphs at ambient conditions. 
Except for Form I, the crystal structures of other polymorphic forms (Forms II–IV) have 
not been reported to date. Since the unit cell data of Forms II and III were already 
reported, it can be assumed that the crystal structures have been determined but not 
reported in the literature. In the case of Form II, the comparison of calculated X-ray 
powder pattern from its crystal structure with the experimental powder pattern was 
reported (Kimura et al., 1999). 
While this work is underway, Hasegawa et al. (2009) reported a detailed analysis 
on the thermal behavior of Form I and showed that this form undergoes a reversible 
structural transformation to a new crystal form upon heating beyond 38 °C. The newly 
transformed phase has been named as Form IH and the phase below 38 °C as Form IL. 
We adopt this naming convention for our discussion in this work. Recently, in an attempt 
to co-crystallize TB resulted in a novel polymorph Form V whose structure is also 
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3.2. Characterization Techniques  
3.2.1. Light Microscopy 
The crystal habit was examined using an optical polarized light microscope 
(Olympus, BX51) connected to a CCD camera. The image was collected using a Soft 
Imaging System’s Analysis image capture software. 
3.2.2. Differential Scanning Calorimetry (DSC) 
DSC analysis was carried out using a Perkin-Elmer Diamond DSC (Perkin-Elmer, 
Beaconsfield, UK). The samples (2–5 mg) were hermetically sealed in aluminum pans 
and heated from 25 to 150 °C at a scanning rate of 10 °C min-1 under nitrogen purge at a 
flow rate of 20 mL min-1. Prior to analysis, the heat of fusion was calibrated with indium 
(purity, 99.999%; melting point, 156.4 °C; heat of fusion, 28.47 mJ mg-1; heating rate; 10 
°C min-1). 
3.2.3. Hot Stage Microscopy (HSM) 
Thermomicroscopic investigations were performed with an optical polarizing 
microscope (Olympus, BX51) equipped with a Linkam hot stage THMS 600 connected 
to a TMS 94 temperature controller (Linkam Scientific Instruments Ltd., Tadworth, 
Surrey, UK). The microscopic images were recorded with a CCD camera attached to the 
Olympus BX-51 microscope (Olympus Optical GmbH, Vienna) at every 10 s time 
interval using Soft Imaging System’s Analysis image capture software. Samples were 
heated over the temperature range of 25 to 150 °C at a constant heating rate of 5 °C min-1. 
3.2.4. Powder X-Ray Diffraction (PXRD) 
PXRD experiments were conducted in Bragg-Brentano geometry with a Bruker 
D8 Advance (Bruker AXS GmbH, Germany) X-ray powder diffractometer  equipped 
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with Cu-Kα source ( λ = 1.5406 Å), a Nickel-filter, 0.3° divergence slit, a linear position 
sensitive detector (Vantec-1) and an Anton Paar Model HTK 1200 high temperature 
chamber. Data were collected at room temperature (RT) over a 2θ range of 5–50° with an 
equivalent step size of 2θ = 0.018° at a scan rate of 0.02° sec-1. For Form IV, data were 
collected over the same 2θ range and with same step size, but at a reduced scanning rate 
of 0.01° sec-1. All samples were rotated to improve the counting statistics. To collect the 
PXRD pattern of Form IH, Form IL was heated to 50 °C at a heating rate of 0.4 °C/sec 
and delayed for 10 minutes for stabilization. Then, the data were collected with the same 
scanning parameters as used before for Form IL. Due to the crystal habit of Forms II and 
III, their experimental peak intensities were strongly affected by preferred orientation 
resulting in severe differences in relative intensities of observed and computed PXRD 
patterns. Hence, their samples were hand ground to a fine powder before collecting the 
powder pattern. 
3.2.5. Scanning Electron Microscopy (SEM) 
Morphology of the TB polymorphs was examined using a high resolution SEM 
(JSM-6700F, JEOL Ltd, Tokyo, Japan) operating at 5 keV under secondary electron 
imaging (SEI) mode. Each sample was mounted on an aluminum stub and platinum 
coated for 1 min by a sputter coater (Cressington 208HR, Cressington Scientific 
Instruments Inc, Watford, UK), prior to analysis. 
3.2.6. Fourier Transform-Infrared Spectroscopy (FTIR) 
A Perkin-Elmer 2000 FTIR spectrometer was used in KBr diffuse reflectance 
mode for collecting the IR spectra of the polymorphs. A total of 32 scans were collected 
over the range of 400–4000 cm-1. 
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3.2.7. Solid-State Nuclear Magnetic Resonance Spectroscopy (SS-NMR) 
Solid-state 13C NMR spectra were collected at RT on a Bruker Avance 400 
spectrometer with a CP-MAS pulse sequence operating at a frequency of 100.61 MHz 
(13C frequency). The samples were packed in zirconium rotors, spun at typical speeds of 
around 6 kHz at the magic angle. A contact time of 2 ms and a relaxation delay of 15 sec 
were used between each scan. Toss program was used to suppress the spinning side 
bands. The chemical shift data was referenced to an external standard of Adamantane. 
3.2.8. Single Crystal X-Ray Diffraction (SCXRD) 
X-ray reflections were collected on a Rigaku Saturn CCD area detector with 
graphite monochromated Mo-Kα radiation (λ = 0.71073 Å). Data were collected and 
processed using CrystalClear (Rigaku) software. For data collection at different 
temperatures, the crystal was allowed to equilibrate at the desired temperature for 15 min 
in a stream of cold nitrogen supplied by Rigaku Cryostat. The structure was solved by 
direct methods and expanded using Fourier techniques. The non-hydrogen atoms were 
refined anisotropically. All hydrogen atoms were fixed at idealized positions except for 
N-H protons which were located from the difference Fourier map and allowed to ride on 
their parent atoms in the refinement cycles. 
3.3. Computational Procedure for Structure Solution of Form IV 
To solve the crystal structure of Form IV, Reflex Plus module in Materials Studio 
molecular modeling (Accelrys Software Inc. Version 4.3.) has been used. Reflex Plus is a 
complete package for structure determination from PXRD data, including indexing, 
Pawley refinement, structure solution and Rietveld refinement. The successive dichotomy 
indexing program X-cell (Neumann, 2003) was used to index the first 23 reflections (2θ < 
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25°) which were shown along with the tabulated values in Fig 3.2. The proposed unit cell 
and the function profile parameters (background coefficients, zero-point shift and peak 
width parameters) were refined over a 2θ range of 5−50° by the Modified Pawley 
method. Pseudo-Voigt function was used for approximating the peak shape profile. The 
background was determined by linear interpolation using 20 terms. Asymmetric 
corrections were applied in the range of 2θ < 45° using Berar-Baldinozzi correction. 




Figure 3.2 The first 23 observed 2θ values used for powder indexing in the structure 
determination of Form IV from powder X-ray diffraction. 
 
The subsequent structure solution was performed by Monte Carlo/parallel 
tempering method using PowderSolve (Engel et al., 1999). The initial molecular model of 

























Chapter 3                                                Experimental – Materials, Methods and Analytics 
 
 45 
13 degrees of freedom (position of the molecule defined by three co-ordinates, 
orientation of the molecule defined by three rotation angles and seven torsional angles as 
shown in Fig. 3.1) were assigned inside an asymmetric unit and the structure solution was 
executed. Hydrogen atoms were not used during the structure solution. March-Dollase 
method (Dollase, 1986) was used to model the preferred orientation effects in the powder 
pattern because this crystal form grows into thin needles.  
For final Rietveld refinement, hydrogen atoms were included and refined by using 
the same degrees of freedom as used for the structure solution. Global isotropic 
temperature factors were applied for modeling the temperature effects on atoms. The 
final Rwp value was converged at 5.38%. The feasibility of hydrogen bonding and close 
contacts were verified before accepting the final solution. 
3.4. Solubility Measurements  
The solubilities of TB were measured at different temperatures starting from 15 to 
60 °C using a UV-Vis spectrophotometer (Varian Cary 50 Conc) which was calibrated at 
229 nm in ethanol solvent. Using a 20 ml crystallization vessel, an excess of TB was 
placed in 10 ml of ethanol, which was maintained at the desired temperature (± 0.1 °C) 
by circulating water in the outer jacket using a Julabo circulator. Immediately after 
addition, 400 rpm agitation was applied by means of a magnetic stirrer. Samples were 
taken at different intervals and measured until constant concentration was achieved.  For 
all samples, the equilibration time was approximately 2–3 hours. During sampling, the 
agitation was stopped and solution was allowed to settle for 1 hour. Approximately, 1 ml 
of the supernatant was then filtered through a millipore (0.2 µm) syringe filter. After 
sufficient dilution, the concentration of the filtered supernatant was determined by 
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measuring the absorbance at 229 nm. PXRD was used to confirm that no polymorphic 
transformation had occurred at the end of the solubility measurement. The solubility of 
each sample is measured in duplicate. 









 Central to the understanding of the origin and control of polymorphism is the 
ability to describe and interpret the similarities and differences in intermolecular 
interactions in the possible polymorphic structures. In this chapter, crystal structures of 
four polymorphic forms of TB (Forms IL, II–IV) were presented and analyzed to 
understand the structural origin of polymorphism in TB. Spectroscopy has been used as a 
complementary technique to further understand the structural features of TB. 
Furthermore, influence of TB molecular dynamics on PXRD patterns is also highlighted.  
4.1. Preparation of Polymorphs  
Form IL of TB was prepared by dissolving TB (3 g) in 6 ml of acetonitrile at 60 
°C and naturally cooled to RT. Form II was prepared by dissolving 1.2 g of TB in 10 g of 
acetonitrile in a 20 ml vial followed by slow addition of 5 ml of water using a pipette into 
the unagitated solution. After one week, crystals were harvested and dried in vacuum at 
40 °C.  
For preparing Form III, the method used by Simmons et al. (1972) was employed 
but this resulted in a mixture of Forms IL and III in our experiments. The microscopic 
observations revealed that these two polymorphs nucleate simultaneously under these 
conditions and it is one of the cases of dimorphic concomitant crystallization (Bernstein 
et al., 1999). To obtain this form, a slightly modified procedure was designed in which a 
saturated solution of TB in ethanol was prepared and then, water was slowly added into 
the unagitated solution using a pipette till spontaneous nucleation of Form III crystals 
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occurred. The crystals were allowed to grow for one day before they were harvested and 
dried in vacuum at 40 °C. The crystals obtained for Forms IL, II and III were pure and of 




Figure 4.1 Scanning electron microscope images of TB polymorphs (a) Form IL (b) Form II (c) 
Form III (d) Form IV. 
 
To prepare Form IV, a slow evaporation method was used which was otherwise 
prepared only by either spray drying (Kimura et al., 1999) or from melt crystallization 
(Burger, 1975). TB (0.5 g) was dissolved in 10 ml of acetonitrile, filtered and then 
transferred to a 20 ml conical flask. The mouth of the flask was covered with aluminum 
foil (a few holes were made in the foil) and left at ambient temperature for slow 
evaporation of the solvent. The crystals of Form IV obtained by this method were not of 
suitable size for SCXRD experiment. Fig. 4.1 shows the SEM images of TB polymorphs. 
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Form IL is of prismatic shape and Form II grows into thin plates. Form III consists of 
long bladed needles whereas Form IV grows like very thin needles. 
4.2. Structural Features of TB Polymorphs 
The crystal structures of TB polymorphs Forms IL and II–IV were determined and 
the corresponding crystallographic data was given in Table 4.1. The comparison between 
the unit cell parameters determined in this work and those reported in the literature 
reveals some interesting observations. (1) The unit cell data reported for Form III (Leary 
et al., 1981) does not match with any of our crystal data; and (2) The unit cell data 
reported for Form II (Kimura et al., 1999) is found to be different from that of ours, but, 
matches with our Form III. A careful examination of the calculated PXRD pattern of 
Form II reported in Kimura et al. (1999) and of the unit cell given for Form II by the 
same authors (CSD refcode ZZZPUS03), reveals a clear discrepancy - the calculated 2θ 
positions of ZZZPUS03 do not match with the 2θ positions reported in their publication. 
It may be possible that they presented the PXRD pattern of Form II but gave the unit cell 
data of Form III.  
4.2.1. TB Conformers and Packing Schemes 
In all the polymorphic forms, TB molecule adopts different conformations hence 
it is another representative case of conformational polymorphism. The conformers found 
in the crystal structures can be divided into two types (U and chair, Fig. 4.2) based on the 
phenyl and alkyl tail orientation with respect to S-N1-C8-N2-C9 plane (refer to Fig. 3.1 
for atom numbering). In the U-type conformation, both the phenyl ring and alkyl tail are 
on the same side of the S-N1-C8-N2-C9 plane, whereas, in chair-type, these are oriented 
in the opposite side of the plane. 
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Table 4.1 Summary of crystallographic data of TB polymorphs. 
 
Crystal data Form IL Form II Form III Form IV 
Empirical 
formula C12H18N2O3S C12H18N2O3S C12H18N2O3S C12H18N2O3S 
Formula weight 270.34 270.34 270.34 270.34 
Crystal habit Prism Plate Needle Needle 
Sample type Single crystal Single crystal Single crystal Powder 
Crystal system Orthorhombic Monoclinic Monoclinic Monoclinic 
Temperature (K) 153 153 153 298 
Color Colorless Colorless Colorless White 
Space group Pna21 Pc P21/n P21/c 
a/Å 19.626(9) 9.087(8) 11.735(2) 10.091 
b/Å 7.803(4) 17.228(3) 9.042(8) 15.646 
c/Å 9.058(4) 17.951(4) 13.732(3) 9.261 
α/° 90 90 90 90 
β/° 90 95.01(3) 103.57(3) 100.49 
γ/° 90 90 90 90 
V/Å3   1387.3(11) 2799.8(10) 1416.4(5) 1438.9 
𝑍 4 8 4 4 
dcalc/g cm-3 1.294 1.283 1.268 1.248 
µ (mm-1) 0.236 0.234 0.231 0.227 (calculated) 
Reflections 
collected 6197 14332 11123 -- 
Unique 
reflections 2118 8617 3514 -- 
Observed 
reflections 2002 8016 2669 -- 
R1[I > 2σ(I)] 0.0572 0.0555 0.0976 Rp = 3.96 % 
wR2 [all] 0.1559 0.1434 0.2742 Rwp = 5.38 %  
Goodness-of-Fit 1.115 1.070 1.159 -- 
Diffractometer Rigaku Saturn CCD area detector 
Rigaku Saturn CCD 
area detector 
Rigaku Saturn CCD 
area detector Bruker AXS 
 
Based on this classification, the molecular packing arrangements in Forms IL and 
II–IV can be classified into four schemes (A–D) as shown in Fig. 4.2. These schemes 
were derived based on the orientation of phenyl ring and alkyl tail of adjacent molecules 
in a hydrogen bonding network. For example, in scheme A, the two adjacent molecules 
are arranged in such a way that the phenyl ring and alkyl tail of TB molecule are laid on 
the opposite side of the S-N1-C8-N2-C9 plane, whereas in scheme B, they are on the 
same side of the plane.  




































Figure 4.3 Overlay of conformers observed in TB polymorphs Forms IL and II–IV (Red-U1 
(Form IL); Green-U2 (Form III); Brown-U3 (Form IV); Pink-Ch1, Yellow-Ch2, Light blue-Ch3, 
Thick blue and Grey-Ch4 (Form II). 
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Table 4.2 The calculated torsional angles (τ1 to τ7) of conformers observed in TB polymorphs (U: 
U-type and Ch: chair type); Occupancy factors for Ch4, a 0.34, b0.66, c0.5. 
 





Form II Form IV 
Ch1 Ch2 Ch3 Ch4 U3 
τ1(C6−C5−S−N1)  141.9 57.7 81.5 141.4 137.2 87.5 94.3 
τ2(C5−S−N1−C8) -50.8 -73.6 -84.7 -67.8 -73.7 -75.6 63.2 
τ3(S−N1−C8−N2) 147.6 163.3 -176.6 164.8 -173.3 176.0 -154.3 
τ4(N1−C8−N2−C9) -174.3 -176.6 174.5 172.7 -177.5 172.3 -174.4 
τ5(C8−N2−C9−C10) 81.5 100.4 -77.8 -83.9 -105.1 -90.8 -85.7 
τ6(N2−C9−C10−C11) -178.8 -67.3 -60.4 -66.0 61.7 -102.4
a  -172.3b -179.3 
τ7(C9−C10−C11−C12) -69.3 -176.9 175.5 -175.4 -178.9 -159.7
c -179.9c 162.6 
 
 
Table 4.3 Hydrogen bond distances and angle parameters with neutron normalized N−H (1.009 




a H···A [Å] D···A [Å] D−H···A [°] 
Form IL N1−H2···O3 1.77 2.739(5) 161 
 N2−H2A···O3 2.03 2.939(5) 148 
 N2−H2A···O1 2.35 3.070(5) 127 
Form III N1−H1···O3 1.83 2.771(5) 154 
 N2−H2A···O3 2.24 3.141(5) 143 
 N2−H2A···O2 2.16 2.903(5) 133 
Form II N1−H1···O3 2.05 2.949(6) 147 
 N2−H2···O3 1.85 2.787(5) 154 
 N1−H1···O1 2.43 3.131(6) 126 
 N3−H3···O4 1.77 2.754(5)   164 
  N4−H4···O4 2.23 3.115(5) 145 
 N4−H4···O5 2.22 3.021(5) 135 
 N8−H5···O12 1.78 2.722(5)         153 
 N7−H6A···O12 2.11 2.972(5) 142 
 N7−H6A···O10 2.25 3.045(5)         135 
 N5−H7···O9 1.78 2.730(5) 155 
  N6−H8···O9 2.13             3.012(5)             145 
 N6−H8···O7 2.61 3.228(5) 120 
Form IV N1−H1···O1 1.96 2.756 151 
 N2−H2···O1 2.40 3.132 152 
 N1−H2···O2 2.35 3.017 119 
For geometric description of hydrogen bond interactions, the following criteria has been used: 
H···A distance < r(A) + r(H) (A: acceptor, D: donor and r: van der Waals radius). 
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Despite forming various schemes, the usual “head-to-tail” packing mode, which is 
typically observed in the crystal structures of urea derivatives persists in all the TB 
polymorphs (Kim et al., 1999). The traditional urea tape motif, a chain of bifurcated 
N−H···O hydrogen bond between NH donors and the carbonyl oxygen acceptor is the 
dominant supramolecular synthon (key intermolecular interaction) in all the crystal 
structures (George et al., 2004). In addition to that, one of the sulfonyl oxygens engaged 
in hydrogen bonding with alkyl amide. The torsional angles for various TB conformers 
were tabulated in Table 4.2 and the extent of conformational diversity of TB molecule 
was highlighted with the overlay of conformers in Fig. 4.3. The geometrical features of 
hydrogen bonding were listed in Table 4.3. 
4.2.2. Crystal Structure Analysis  
 
Forms IL and III. Form IL crystallizes in the orthorhombic, Pna21 space group whereas 
Form III crystallizes in the monoclinic, P21/n space group. Both polymorphs crystallize 
with one molecule of TB in the crystallographic asymmetric unit (𝑍′ = 1) and adopt the 
U-type conformation. However, significant differences were observed in the orientation 
of the terminal alkyl chain of these two conformers. The torsional angles τ6 and τ7 are in 
anti- and gauche- conformation in Form IL, whereas they are in gauche- and anti- 
conformation in Form III, respectively (see Table 4.2).   
The crystal packing diagrams of Forms IL and III were shown in Fig. 4.4 and 
both forms adopt the packing scheme A. They are also similar in terms of hydrogen 
bonding and the other structure stabilizing interactions (see Table 4.3). The one-
dimensional (1D) chains involving N−H···O hydrogen bonds run along [0 0 1] and [0 1 0] 
in Forms IL and III, respectively. The concomitant nucleation of these two forms from 
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the crystallization batches could be because of their similarities in conformation, 




















Figure 4.4 Crystal packing diagrams of TB polymorphs (a) Form IL (b) Form III. 
 
Chapter 4                             Structural and Stability Features of Tolbutamide Polymorphs 
 
 55 
Form II. Form II crystallizes in the monoclinic, Pc space group with four molecules of 
TB in the crystallographic asymmetric unit (𝑍′ = 4). Unlike the conformers in Forms IL 
and III, the TB molecule adopts the chair type conformation in this polymorph. It is 
interesting to note that all symmetry independent molecules (Ch1, Ch2, Ch3 and Ch4) are 
conformationally different (i.e., conformational isomorphism) (Nangia, 2008).  
 
Figure 4.5 Crystal packing diagram of Form II (Pink-Ch1; Yellow-Ch2; Light blue-Ch3; Thick 
blue and Grey-Ch4). 
 
The major differences were observed in τ1 and τ6 torsion angles. In Ch1 and Ch4, 
the torsion around τ1 is in gauche- conformation, whereas in Ch2 and Ch3 it is in anti- 
conformation. The torsion around τ6 is in gauche- conformation except for Ch4 which is 
found to be in anti- conformation. In Ch4, the two terminal carbon atoms (C55 and C57) 
were found to be disordered. The disorder at C55 was modeled over two sites with an 
occupancy ratio of 66:34, whereas C57 was modeled with an occupancy ratio of 50:50. 
For clarity, these disordered atoms were shown in two different colors (thick blue and 
grey) for Ch4 molecule in the overlay (Fig. 4.3) and packing diagrams (Fig. 4.5).  
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As shown in Fig. 4.5, the crystal structure of Form II reveals two types of packing 
schemes (C and D). Conformers Ch1 (pink molecule) and Ch2 (yellow molecule) follow 
scheme D i.e. phenyl rings and alkyl tails on opposite side of the plane. They form 1D 
chains along [1 0 0] direction involving N−H···O hydrogen bonds. Conformers Ch3 (thick 
blue) and Ch4 (light blue) form another 1D network which runs perpendicular to the 1D 
tape motif formed by Ch1 and Ch2 molecules. There are some significant differences in 
the orientation of molecules in the formation of these networks. When Ch1 and Ch2 are 
involved, the asymmetric molecules were related by a mere translation followed by a 2-
fold rotation whereas in the other network with Ch3 and Ch4, they are related by a glide 
plane followed by a 2-fold rotation. Because of these differences, a single packing 
scheme (D) was observed between Ch1 and Ch2 while two types of packing schemes (C 
and D) were observed between Ch3 and Ch4. The structure is further stabilized by 
various C−H···π and C−H···O (2.86 – 3.96 Å and 100 –164°) interactions.  
Form IV. Despite several attempts to obtain the single crystals suitable for X-ray data 
collection, Form IV resulted only in crystalline powder. An alternative is the structure 
solution from the PXRD pattern. In this work, the direct space approach with the Monte 
Carlo method followed by Rietveld refinement has been used and the structure solution 
was implemented in Materials studio environment. The powder indexing unambiguously 
found a monoclinic unit cell with P21/c space group with one molecule in the asymmetric 
unit (𝑍′ = 1). The high values of absolute figure of merit (Fa) of 1999 (0.0055, 35)) and 
relative figure of merit (Fr) of 3.45 strongly suggest that the converged solution is the 
correct one (Neumann, 2003). From the calculated unit cell volume, four molecules (𝑍 = 
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4) were expected in the unit cell. Fig. 4.6 shows the difference plot of Rietveld simulated 
profile and experimental profile. 
 
Figure 4.6 The difference plot of Rietveld simulated and experimental powder patterns of Form 
IV. 
 
The unit cell (a = 10.09 Å, b = 15.64 Å, c = 9.27 Å, β = 100.5°, V = 1440 Å3) was 
found to be closely related with that of Form IL. The a-axis is halved and b-axis is 
doubled in the case of Form IV when compared to Form IL. The TB molecule adopts the 
U-type conformation. When compared to other U-type conformers, major differences 
were observed in the alkyl tail orientation. The torsion angles τ6 and τ7 are both found to 
be in anti conformation. The crystal packing diagram was shown in Fig. 4.7. The adjacent 
molecules were related by a mere translation followed by a 2-fold relation. This leads to a 
unique packing scheme, scheme B, however, the 1D hydrogen bond urea tape motif 
persists in the crystal structure involving N−H···O  hydrogen bonds which runs along [0 0 
1] direction. 




Figure 4.7 Crystal packing diagram of Form IV. 
 
4.3. IR Spectroscopy  
Comparison of FTIR spectra of TB polymorphs was shown in Fig. 4.8. The 
carbonyl stretching was observed at 1662, 1659, 1666 and 1665 cm-1 for Forms IL and II–
IV, respectively. This suggests that carbonyl group is involved in a similar hydrogen 
bonding in all the polymorphs. This is consistent with the hydrogen bonding patterns 
observed in the crystal structures. The symmetric and asymmetric stretching frequencies 
of sulfonyl group are observed at 1336, 1156 cm-1 for Form IL, 1347 and 1164 cm-1 for 
Form II, 1342, 1166 cm-1 for Form III and 1349, 1166 cm-1 for Form IV. This suggests 
that sulfonyl group was involved in a stronger hydrogen bonding in Form IL compared to 
other forms.  
In all the crystal structures, the sulfonyl group involves in hydrogen bonding with 
alkyl amide and in other intermolecular C−H···O interactions. The N−H···O distances are 
3.07 Å, 3.106 Å, 2.903 Å and 3.01 Å for Forms IL, II, III and IV, respectively. This 
comparison suggests that sulfonyl group in Form III has a stronger hydrogen bonding 
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with alkyl amide among others. This is inconsistent with IR absorption data and the lower 
IR absorption frequency for Form IL can be attributed to other strong intermolecular 
interactions around sulfonyl oxygens. The IR absorption for the sulfonyl amide stretching 
is observed at 3328, 3338, 3331 and 3338 cm-1 for Forms IL and II–IV, respectively. This 
is consistent with the hydrogen bonding involving sulfonyl amide and carbonyl group. 
 
Figure 4.8 FTIR spectra of TB polymorphs. 
 
The alkyl amide N−H stretch is observed at 3172, 3179, 3178 and 3182 cm-1 for 
Forms IL and II−IV, respectively. This group involves in hydrogen bonding with both 
carbonyl and sulfonyl groups in all the polymorphs and these interactions are strongest in 
Form IL and weakest in Form IV and in accordance with IR absorption. Apart from 
hydrogen bonding features, another difference in IR spectra was observed in the aliphatic 
C-H stretching region (2800−3000 cm-1). The respective methyl group (one at the end of 
the tail and another connected to aromatic group) stretching frequencies were observed at 
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2960, 2931 cm-1 for Form IL, 2955, 2932 cm-1 for Form II, 2952, 2922 cm-1 for Form III 
and 2966, 2929 cm-1 for Form IV. This represents the conformational variations observed 
in the orientations of alkyl tail and aromatic ring in various polymorphs. 
4.4. Solid-State NMR Spectroscopy 
 
Figure 4.9 SS-NMR spectra of TB polymorphs. 
 
CPMAS 13C spectra of Forms IL and II–IV were shown in Fig. 4.9. The 13C 
resonances were assigned according to Kimura et al. (1999). NMR chemical shifts are 
indicative of molecular arrangement in the crystal lattice and for NMR principle and its 
data interpretation refer to section 2.5.2. In the case of Forms IL and III, the number of 
resonances is equal to the number of carbon atoms in the molecule, so it can be 
concluded that the asymmetric unit consists of one molecule. This is consistent with our 
crystal data. Between these two forms, the major differences in the chemical shifts were 
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observed around C5 and C10 (131.8, 31.8 for Form IL and 140.6, 33.6 for Form III for 
C5 and C10, respectively). These differences can be attributed to the torsional differences 
observed around C5−S (phenyl ring orientation) bond and C10−C11 bond (alkyl tail 
orientation) in the conformers found in these two forms.  Apart from these differences, 
the spectra look quite similar. This can be easily recognized from the fact that they adopt 
the same type of packing scheme and form similar hydrogen bonding networks. In the 
case of Form II, there are three resonances for each of the carbon atoms of TB molecule 
indicating that at least three crystallographically nonequivalent molecules are present in 
the unit cell. This is in accordance with the crystal structure of Form II as it has four 
molecules in the asymmetric unit.  
The NMR spectrum of Form IV is highly consistent with the determined crystal 
structure from powder diffraction in that all carbons were crystallographically equivalent 
resulted in single resolved peaks indicating that this polymorph has a single molecule in 
the asymmetric unit. Though this form adopts the U-type conformation like Forms IL and 
III, major differences in carbon resonances were observed at alkyl tail carbons (C9–C12) 
due to the different packing scheme adopted by this polymorph. In all the TB 
polymorphs, the chemical shift for C8 observed in a narrow range (154.5–155.3), 
presumably because in all the cases it is participating in hydrogen bonding as an acceptor. 
4.5. Powder X-Ray Diffraction Analysis  
To verify the differences between Forms IL and IH, we have collected the PXRD 
pattern of Form IH and compared with that of Form IL as shown in Fig. 4.10. The 
differences were mainly evident in the 2θ region of 19−21°. The similarity in the low   
Chapter 4                             Structural and Stability Features of Tolbutamide Polymorphs 
 
 62 
angle region (5° < 2θ < 19°) highlights the isomorphous characteristic of these two forms 
with minor conformational changes (Hasegawa et al., 2009). 
 
Figure 4.10 Comparison of experimental (RT) and calculated (153 K and RT) PXRD patterns of 
TB polymorphs. 
 
Fig. 4.10 also shows the comparison of experimental PXRD patterns of TB 
polymorphs with the calculated patterns from their respective crystal structures 
determined at RT and 153 K. To our surprise, when compared with 153 K structures, 
significant differences were observed particularly in the 2θ region of 19–25°. Typically, 
deviation in peak positions in powder patterns is expected due to thermal contraction of 
the lattice at low temperature (Stephenson, 2006). If the unit cell contraction is isotropic, 
these differences reflect in shifting of peak positions to higher angles. If it is anisotropic, 
some peaks may shift to lower angles and some to higher angles. Rarely, severe 
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differences in intensities may also occur which can be attributed to molecular motion in 
the solid state (Cruickshank, 1956).  
In the case of TB polymorphs, the differences in the PXRD patterns are 
manifested not only in peak shifting to both higher and lower 2θ values but also in peak 
splitting. These differences are so severe that it is difficult to identify the polymorphic 
phase. Hence, the crystal structures were redetermined at RT and the calculated PXRD 
patterns were compared with the experimental patterns as shown in Fig. 4.10. Now, the 
powder patterns are in good agreement and this implies that the differences observed in 
low temperature powder patterns were due to thermal effects.  
To verify the lattice contraction and its effect on crystal structures, we have 
compared the unit cell data and the molecular conformations of the three polymorphs at 
RT and 153 K. In the case of Form II, we have determined the crystal structures at 
different temperatures between RT and 153 K to track the changes occurring in its crystal 
structure. In the case of Form IL, the anisotropy of lattice contraction is ∆a/a × 100 = 
2.95 %, ∆b /b × 100 = 0.35% and ∆c/c × 100 = 0.35%. The contraction along the b- and 
c-axis is similar but the contraction along the a-axis is nearly 10 times more. In the case 
of Form III, the anisotropy is ∆a/a × 100 = 0.85%, ∆b /b × 100 = 0.33%, ∆c /c × 100 = 
2%. In the case of Form II, it is ∆a/a × 100 = 0.73%, ∆b /b × 100 = 0.24%, ∆c /c × 100 = 
1.63%. The overall anisotropy and contraction in the cases of Forms II and III are 
relatively less compared to Form IL. This explains the greater deviation observed in peak 
positions for Form IL compared to other forms. These differences are much more severe 
at higher 2θ values.  
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Table 4.4 Torsional changes calculated in the alkyl tail of TB conformers observed in Forms IL, 
II and III at different temperatures (Ch4 is not shown because of disorder in the alkyl tail). RT-
Room Temperature; LT-Low Temperature (153K); τ∆ - Absolute torsional change. 








































































Table 4.4 lists the torsional variation observed in TB conformers found in the 
structures determined at RT and 153 K. The major changes were observed in the alkyl tail 
of the TB molecule (τ5, τ6 and τ7). According to Threlfall, upon decreasing the 
temperature, the molecule releases the extra thermal energy by weakening of shortest 
intermolecular interactions followed by unwinding the structure with intermolecular 
torsional changes around the hydrogen bonds (Threlfall, 2003). In the case of TB, we 
could rationalize that, as the temperature decreases, the strongest interactions such as 
N−H···O hydrogen bonds loosen up to allow conformational changes in the alkyl tail 
(probably this part of the molecule has the lowest energy barrier). This would have forced 
the cell axes to contract anisotropically to accommodate these conformational changes. 
Fig. 4.11 shows the calculated PXRD patterns of Form II at different temperatures 
ranging from RT to 153 K. As the temperature decreases, the peak at 19.6° corresponding 
to (2 0 0) plane was observed to split into two peaks. The new peak appeared 
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corresponded to (0 0 4) plane for which the intensity increased as the temperature 
dropped further. These changes can be attributed to the variation in the unit cell 
parameters and molecular conformational changes. The fact that the nature of this 
variation is continuous indicates that the differences in PXRD patterns are not due to 
phase transformation. 
 
Figure 4.11 Comparison of calculated PXRD patterns of Form II at different temperatures. 
 
4.6. Thermal Analysis 
DSC thermograms of the TB polymorphs were shown in Fig. 4.12 and the 
corresponding data was summarized in Table 4.5. The calculated enthalpy values were 
the averages of three independent experiments. Hess’s law of heat summation (∆𝑓𝑢𝑠𝐻 +
∆𝑡𝑟𝑠𝐻) was used to estimate the heat of fusion as no direct melting was observed except 
Form IH. The thermogram of Form IL shows two peaks; a small endotherm at 40 °C 
followed by another endotherm at 128 °C. The first peak was ascribed to a kinetically 
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reversible polymorphic transition to Form IH (Kawakami, 2007; Hasegawa et al., 2009) 
and the second peak was ascribed to melting of Form IH. 
 
Figure 4.12 DSC thermograms of TB polymorphs at a heating rate of 10 °C min-1. 
 
 
Table 4.5 DSC data of TB polymorphs. 
 





-1) b∆𝑓𝑢𝑠𝐻 (KJ mol
-1) 
Form IH 128 -- -- 23.8 
Form IL -- 40 +1.9 (IL→IH) 25.7 
Form II 117 -- +2.2 (II→IH) 26 
Form III -- 106 +1.72 (III→IH) 25.6 
Form IV -- 94 -1.3 (IV→IH) 19.8 
aheat of transition bheat of fusion (calculated by Hess’s law of heat summation) 
 
In the case of Form II, a sharp endothermic melting peak at 117 °C was observed 
followed by an exotherm due to recrystallization of Form IH from the melt of Form II. 
An endotherm at 128 °C due to the melting of Form IH was subsequently observed. This 
behavior was visually observed under hot stage microscope (HSM) and shown in Fig. 
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4.13. When Form II crystals were heated on the hot stage, in a temperature range of 
120−123 °C, a series of events like melting, nucleation and growth of new crystals from 
the melt were observed simultaneously. The prismatic shape and melting point (128 °C) 











Figure 4.13 Hot stage microscope images of Form II (a) plated crystal of Form II at 40 °C (b) 
plated crystal of Form II at 100 °C (no change observed) (c) melting of Form II at 120 °C (d) and 
(e) prism like crystals characteristic of Form IH growing from the melt of Form II (f) melting of 
Form IH at 130 °C. 
 
On the other hand, Forms III and IV undergo an endothermic transition at 106 °C 
and an exothermic transition at 94 °C to Form IH, respectively. The thermal behavior of 
Forms I–IV is consistent with Burger’s forms (Burger, 1975). However, some differences 
in the thermal behavior of Forms II and III were observed when compared to Kimura’s 
forms (Kimura et al., 1999). The DSC thermograms of Forms II and III in the current 
work closely matches with those of Forms III and II in Kimura’s work, respectively. 
4.7. Energy-Temperature Diagram of TB Polymorphs  
Based on the DSC data listed in Table 4.5, the relative thermodynamic 
relationships among TB polymorphs are estimated and a schematic energy-temperature 
Chapter 4                             Structural and Stability Features of Tolbutamide Polymorphs 
 
 68 
diagram (E-T diagram, Fig. 4.14) was constructed. For more details on constructing E-T 
diagrams, refer to section 2.3.3. In the case of Forms IL and IH, the nature of transition is 
reversible and only one of the two forms is experimentally accessible. So for clarity, the 
virtual states of these two forms were shown as dotted lines in the E-T diagram.  
From the DSC analysis, it is clear that all the TB polymorphs undergo transition 
to a high temperature stable Form IH. According to the heat of transition rule, the 
polymorphic pairs III/IH and IV/IH should be enantiotropically and monotropically 
related respectively. On the other hand, Form II shows a melting transition to Form IH 
and according to the heat of fusion rule, these two polymorphs should be 
enantiotropically related. The stability relationships between other polymorphic pairs 
cannot be derived from DSC data because the melting points of Forms IL, III and IV are 
not known. However, the constructed E-T diagram allowed us to derive these 
relationships. 
In the case of Form IV, the course of its 𝐺 isobar clearly suggests that it should be 
monotropically related to all the other forms. It is also clear from E-T diagram that 𝐺 
isobars of Forms III and IL should intersect below the transition temperature of Forms IL 
and IH (~ 40 °C) to make this pair enantiotropic. This suggests that Form III is less stable 
than Form IL below their transition temperature after which Form III becomes more 
stable. Our previous experiments suggest that Forms III and IL concomitantly crystallize 
at RT and finally only Form IL survives. This implies that the transition temperature 
between these two forms should be between RT and 40 °C. The only thermodynamic 
relationship that is not clear is that between II/III pair. It is difficult to conclude from E-
T diagram because the melting point of Form III is not available.  




Figure 4.14 Schematic energy-temperature diagram of TB polymorphs. 𝑇𝑓𝑢𝑠: Melting 
temperature, 𝑇𝑡: Transition temperature, ∆𝑡𝑟𝑠𝐻: Enthalpy of transition, ∆𝑓𝑢𝑠𝐻: Enthalpy of 
fusion, 𝐺: Gibbs free energy, 𝐻: Enthalpy, LIQ: Liquid phase (melt). The horizontal double 
headed arrows mark temperature ranges where either Form II or IH is the thermodynamically 
stable form. 
  
The E-T diagram suggests that the stability order of TB polymorphs at ambient 
conditions should be Form II > Form IL > Form III > Form IV with Form II being the 
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temperature of Forms IH and II, we have measured the solubilities of Forms IH, IL and II 
in the temperature range from 15 to 60 °C in ethanol. Fig. 4.15 shows the Van’t Hoff’s 
plot. We have not measured the solubilities of Form IL between 30–40 °C because the 
transformation from Form IL to IH is highly probable in this range. These measurements 
suggest that Form II is less soluble than Form IL and hence it should be the 
thermodynamically stable form at RT. The Van’t Hoff’s plot of Form II intersects that of 
Form IH at ~80 °C. This suggests that these two forms are enantiotropically related and 
Form IH is the stable form above ~80 °C. 
Figure 4.15 Van’t Hoff’s plot of TB polymorphs in ethanol (The lines are extrapolated to the 
intersection point to estimate the transition temperature showed as dotted line), T: temperature in 
Kelvin, Solubility: g of TB per g of ethanol. 
 
4.8. Further Verifications 
These measurements were further verified by solution mediated transformation 
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Form IL to the more stable Form II in a saturated solution of ethanol at RT. The high 
temperature transition from Form II to IH was verified using the HSM. Form II crystals 
were suspended in paraffin oil in a hot stage crucible and heated to 100 °C. During the 
heating, the crucible was rotated to dissolve the crystals. Then, the crucible was kept at 
100 °C for a few minutes and cooled down to 95 °C at a rate of 1 °C min-1. The growth of 
prismatic crystals typical of Form IH was observed (see Fig. 4.16 (b)). This suggests that 
the transition temperature from Form II to IH exists between RT and 95 °C. 
 
 
Figure 4.16 (a) Polymorphic transformation of Form IL → II in ethanol solution at RT (b) 
Polymorphic transformation of Form II → IH in paraffin oil at 95 °C.  
 
The calculated densities from the crystal structures at RT are: 1.246, 1.252, 1.233 
g/cm3 for Forms IL, II and III, respectively. The density rule (refer to section 2.3.3) 
suggests that the stability order should be Form II > Form IL > Form III at absolute zero, 
and this is consistent with our previous results. But, the calculated densities of low 
temperature crystal structures are: 1.294, 1.283 and 1.268 g/cm3. In this case, density rule 
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This is not surprising because these two forms show different thermal contraction 
properties and 𝑍′ parameter, and density rule often fails in such cases (Sun, 2007). 
The crystal lattice energies were calculated using COMPASS with force field 
assigned parameters in Materials Studio (Accelrys Software Inc. Version 4.3.). These 
values at 153 K are: -50.6, -46.9, and -46.2 kcal/mol and at RT are: -49.1, -45.9 and -44.8 
kcal/mol for Forms IL, II and III, respectively. Again, the energy order at both 
temperatures is consistent with IL/III and II/III pairs, but fails with respect to IL/II pair. 
This can be attributed to the disorder found in the alkyl chain of TB molecule in Form II 
structure which leads to a higher R-factor. The calculated density and lattice energy 
values of Form IV are 1.248 g/cm3 and -43.3 kcal/mol. We cannot compare these values 
with other forms because this structure is determined from the PXRD data. But, the 
higher lattice energy and lower density (compared to low temperature structures) 
indicates that it is the least stable among the others. 
4.9. Further Discussion  
Although we could identify the TB polymorphic forms prepared in this work with 
Burger’s Forms I–IV, discrepancies were observed in their relative stability. Results from 
different studies variously suggest that the thermodynamically stable polymorph at 
ambient conditions should be Form I (Burger’s work); Form III (Rowe’s work); and 
Form II (present work). Hence, we have decided to scrutinize their results to find the 
reasons for these discrepancies. In Rowe’s work, it is difficult to identify the stable 
polymorph because no characteristic data was provided. But, the morphological 
description indicates that it crystallizes with a very fine needle shaped morphology which 
tends to form a highly flocculated structure. Interestingly, this morphology closely 
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matches with Form II obtained from our slurry experiments (refer to Fig. 4.16 (a)). 
Hence, we suspect that they might have misinterpreted the more stable phase as Form III 
which was actually Form II.  
In Burger’s case, the discrepancy is mainly observed in the stability of Form II. 
Burger reported that Form II is a metastable polymorph, but the present work suggests 
that it is the stable polymorph. Kimura et al. who further investigated Burger’s forms and 
studied the transition behavior of Form IV under different humidity conditions suggested 
that Form IV transforms to Form II which then converts to Form I at 75% RH in the 
temperature range of 35–70 °C. This is consistent with Burger’s stability order but 
contradicts our observation that Form II is the thermodynamically stable polymorph in 
this temperature range. When we tested our Form II at 75% RH and 45 °C for several 
months, no such transformation was observed. This raises the question of whether our 
Form II is the same as Burger’s reported Form II (or Kimura et al.’s Form II). Further 
structural investigations may be needed to fully answer this question.  To clarify the 
nomenclature amongst the various publications referring to TB, a table summarizing the 
known reports on TB polymorphs and inconsistencies in nomenclature was provided 
(Table 4.6). The discrepancies found in their relative stability and structural data and 
clarifications provided by current work were also shown. 
4.10. Summary 
The conformational flexibility of the TB molecule and strong hydrogen bonding 
ability of secondary amide via carbonyl and sulfonyl groups facilitate this drug to 
crystallize into different polymorphic forms (Forms (IL, IH) and II–IV). All the 
polymorphs show similar hydrogen bonding motif (urea tape motif and hydrogen 
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bonding to sulfonyl group) with different orders of magnitude. The major differences 
were observed due to the rich torsional freedom available for the terminal alkyl chain of 
TB molecule. Forms IL, III and IV adopt different U-type conformations, whereas Form 
II adopts four different chair type conformations (Ch1–Ch4). These molecular features 
clearly suggest that this system is a representative case of conformational polymorphism. 
Due to conformational differences, the molecular orientations in hydrogen bonding 
networks are considerably different and result in different packing arrangements in each 
polymorph. 
By reporting the crystal structures of various polymorphic forms of TB, the present 
work resolves several discrepancies in the published data on the structural information of 
the polymorphs of this API. This study also highlights the influence of anisotropic 
thermal motion of molecules on PXRD patterns of solids. 
Based on the DSC data, the relative thermodynamic relationships of TB 
polymorphic pairs were evaluated and graphically visualized in a schematic energy-
temperature diagram. Form II is found to be the thermodynamically stable polymorph 
from absolute zero to ~353 K and beyond which Form IH is the stable polymorph. These 
observations were further verified by solution mediated transformation experiments. The 
discrepancies in the literature related to the relative stability of TB polymorphs at 
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Table 4.6 Comparison of current work with previous work reported in the literature on TB 
polymorphs. 
 




Characterization and Relative 
Stability 
Forms Equivalent in Present Work and 




Wunsch (1969)  
 
Forms I, II and 
III  
Hot stage microscopy 
 
Forms (IL, IH)a, II and IV 
Simmons et al. 
(1972)  
 
Forms A  and B DSC, FTIR and PXRD Forms (IL, IH) and III  
Burger (1975)  Forms I, II, III 
and IV 
DSC, FTIR and  Hot-stage  
microscopy  
 
Stability order (ambient): 
Form I  > Form III > Form II  > 
Form IV 
 
Stability relationship with Form I: 
Form II: enantiotropic, Tt < 37°C 
Form III: enantiotropic, Tt < 37°C 
Form IV: monotropic 
Forms (IL, IH), II, III and IV 
 
Stability order (ambient): 
Form II > Form IL > Form III > Form 
IV 
 
Stability relationship with Form (IL, 
IH): 
Form II: enantiotropic 
Ttb (II →IH) ( ~ 80 °C) 
Form III: enantiotropic  
25 °C < Tt (IL →III) < 40 °C 
40 °C < Tt (IH →III) < 106°C 
Form IV: monotropic 
 
Nirmala et al. 
(1981) & 





Single crystal XRD 
 
Orthorhombic, Pna21, Z = 4 





Crystal structure agrees with present 
work. 
Leary et al. (1981)  Forms A and B DSC and Single crystal XRD 
 
Form B:  monoclinic, P21, Z = 2, 
 a = 8.11 Å, b = 8.96 Å, c = 10.19 
Å,   β = 101o 
 
Forms (IL, IH) and III 
 






Forms I and III 
 
Form III is more stable than Form 
I below 75oC (using solubility 
measurements). 
 
Forms (IL, IH)  and II 
 
Stability order and transition 
temperature agree with current work. 
 
Kimura et al. 
(1999) 
Forms I, II, III 
and IV 
 
DSC, PXRD, FTIR, SS-NMR  and 
Single-Crystal XRD 
 
Form II: monoclinic, P21/n, Z = 4, 
a = 11.81 Å, b = 9.06 Å, c = 13.98 
Å, β = 104.5o 
 
Stability order (ambient): 
Form I > Form III > Form II > 
Form IV 
 
Forms (IL, IH), II, III and IV 
 
DSC thermograms of Forms II and III 
probably correspond to those of Forms 
III and II in the current work, 
respectively. 
 
Unit cell data reported for Form II was 
actually that of Form III. 
 
Stability order (ambient) : 
Form II > Form IL > Form III > Form 
IV 
 
a Form IL: Form I below 38°C; Form IH: Form I above 38°C  b Tt : Thermodynamic transition temperature





PAT AND EXPERIMENTAL SETUP 
 
 
5.1. FDA’s PAT Initiative 
Pharmaceutical production has historically involved the manufacture of the 
finished product via fixed batch recipes, followed by laboratory testing to ensure its 
quality. Such a Quality by Testing (QbT) approach may satisfy the customer needs, but 
sometimes at the expense of cost and loss of profit to the company e.g. longer cycle 
times, product variability, failed batches etc. To address this issue, FDA has changed its 
regulatory approach from focusing on end product to process and released a new 
guidance to the industry. The desired goal is to design and develop well understood 
processes that will consistently ensure a predefined quality at the end of the process. This 
new approach is referred to as Quality by Design (QbD).  
PAT is the critical element in QbD approach which includes process analyzers, 
chemometrics (e.g. data based modeling techniques) and process monitoring and control 
techniques (multivariate supervision and diagnosis strategies). Process analyzers are in 
situ sensors which collect the data related to process variables and product quality 
attributes. Chemometrics are necessary to extract the ‘relevant information’ from the 
highly correlated data generated by process analyzers to develop quantitative models. 
Process monitoring and control techniques facilitate detecting faults and diagnosing in 
real time to ensure process control. 
5.2. QbD based Crystallization Process Development for the Desired Polymorph    
QbD based strategies for the design of robust crystallization of the specific 
polymorph have been discussed by a few authors (Threlfall, 2000; Lin et al., 2007; 
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Bohlin et al., 2009). These are based on interacting with thermodynamics and 
crystallization kinetics of polymorphs to identify regions (design space) where 
spontaneous nucleation of the targeted form is guaranteed. Experimental characterization 
of design space has been reported in the case of stavudine (Lu and Rohani, 2009), 
famotidine (Lu et al., 2007) and stearic acid (Sato and Boistelle, 1984).     
Essentially, to determine a design space for obtaining a specific polymorph, the 
following basic information must be gathered. 
1. Selection of the desired form 
2. Solubility curves of polymorphs 
3. Metastable zone width 
4. Polymorph transformation kinetics 
5.2.1. Selection of the Desired Form  
Once a comprehensive screening for all possible polymorphs has been performed, 
the desired one should be selected based on careful characterization including the 
stability and formulation properties. The ideal solid form should be thermodynamically 
stable, have robust chemical and physical stability, appropriate solubility and suitable 
drug substance and drug product processability (Ticehurst and Docherty, 2006). 
According to Miller et al. (2005), the thermodynamically most stable form is almost 
always considered the most desired crystal form because it has the lowest propensity to 
phase transformation. However, metastable forms are sometimes deliberately chosen 
usually for better solubility and thus enhanced bioavailability (Singhal and Curatolo, 
2004). 
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5.2.2. Solubility Data of Polymorphs 
  Accurate solubility data is a crucial part of the design, development and operation 
of crystallization process. As solubility defines the crystallization boundary, it is 
important in assessing process yield, level of supersaturation and polymorph stability. A 
typical experimental procedure for solubility measurement involves agitation of a 
solution that contains excess solids at a constant temperature for sufficient time (4–24 
hours) to allow for equilibration followed by sampling the solution and analyze to 
determine the solute concentration (Mullin, 1993). There are various techniques available 
for solution concentration analysis which includes gravimetry or using analytical 
instruments such as HPLC, UV-Vis spectroscopy etc (Rohani et al., 2005).  
 A more modern solubility measurement method uses online PAT tools for 
monitoring the concentration changes in the solution. Such a real time, inline monitoring 
allows the user to optimize the equilibration time, thus preventing any solid phase 
changes which may occur when metastable polymorphs are involved. Apart from 
solubility measurements, reliable in situ monitoring of solute concentration is a 
prerequisite for the control of supersaturation which is a key parameter in crystallization 
process control.  
There are a wide variety of PATs available for this purpose. The feasibility of 
Attenuated Total Reflectance-Fourier Transfer Infrared Spectroscopy (ATR-FTIR) for 
the in situ measurement of solute concentration in dense liquid slurries has been 
demonstrated (Dunuwila et al., 1994; Dunuwila and Berglund, 1997). Currently, it is the 
most widely used PAT in crystallization and a number of applications have been reported 
where ATR-FTIR has been utilized for process monitoring and control (Lewiner et al., 
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2001; Togkalidou et al., 2001; Fujiwara et al., 2002; Doki et al., 2004; Liotta and 
Sabesan, 2004; Pollanen et al., 2005; Scholl et al., 2006; Cornel et al., 2008; Borissova et 
al., 2009; Kee et al., 2009a). Conductometric probes (Amathieu and Boistelle, 1988; 
Garcia et al., 2002), density meters (Gutwald and Mersmann, 1990), NIR spectroscopy 
(Zhou et al., 2006) and ATR UV-Vis spectroscopy (Howard et al., 2009) have  also been 
applied for in-line concentration measurement. 
5.2.3. Metastable Zone Width Measurements 
MZW measurements reflect the nucleation kinetics of a crystallizing system and 
they have long been used to estimate primary nucleation kinetics (Nyvlt, 1968; Nyvlt et 
al., 1985; Kim and Mersmann, 2001). In a polymorphic system, nucleation kinetics of 
different polymorphs can be experimentally determined by measuring MZW 
corresponding to each polymorph (Teychene and Biscans, 2008). Unlike solubility, 
MZW is a kinetic property typically influenced by a variety of operating parameters 
including saturation temperature, rate of supersaturation generation, impurity level, 
mixing and solution history (Ulrich and Strege, 2002). It is therefore important to 
characterize MZW under a specific set of operating conditions. 
For a given solute-solvent system, MZW can be measured either by isothermal or 
polythermal method (Garside et al., 2002). In the isothermal method, induction time (i.e., 
the time elapsed between creation of supersaturation and the formation of crystals) is 
measured. This is achieved by the rapid cooling of a saturated solution to a predefined 
temperature and isothermally kept until the nucleation is detected. In a polythermal 
method, a saturated solution is cooled at a fixed cooling rate until nucleation occurs. 
MZW can be calculated as the difference between the nucleation and saturation 
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temperatures. However, when dealing with polymorphic compounds, in addition to 
measuring induction time/nucleation temperature, the solid crystallized should also be 
characterized.  
For MZW measurements, a wide variety of techniques have been applied to detect 
the onset of nucleation. Kubota (2008) classified them into two categories; first category 
includes those techniques which detect changes related to the amount of grown nuclei. 
Methods using naked eye (Sohnel and Mullin, 1988), a particle counter (Barrett and 
Glennon, 2002; Fujiwara et al., 2002) and turbidity meter (Gerson et al., 1991) come 
under this category. The second category includes those which detect changes in solution 
concentration. ATR-FTIR (Fujiwara et al., 2002), ultrasound sensor (Titiz-Sargut and 
Ulrich, 2003; Chaleepa et al., 2010), densitometer (Marciniak, 2002) and electrical 
conductivity (Lyczko et al., 2002) fall into this category. Since these techniques cannot 
distinguish the solid forms, the crystals are usually separated and subjected to analysis to 
detect the type of polymorph nucleated.  
Teychene and Biscans, (2008) measured the nucleation rates of eflucimibe 
polymorphs by measuring the induction time using naked eye followed by solid phase 
analysis using PXRD. Similar studies can be found in the literature (Anuar et al., 2009; 
Svard et al., 2009). However, this approach may lead to erroneous conclusions as it 
involves the risk of polymorphic transformation while handling the solid phase. Recently, 
Raman spectroscopy has been shown as a method for monitoring the onset of nucleation 
which detects the associated change in solution opacity at the time of nucleation with an 
additional advantage that it allows for the in situ detection of the type of polymorph 
nucleated (Hu et al., 2005; Owen et al., 2005; Wu et al., 2009).  
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5.2.4. Polymorph Transformation Kinetics 
Knowledge of possible phase transformations, their kinetics and rate controlling 
mechanism in a polymorphic system is essential when designing a process to isolate the 
desired form. This information is useful for determining crystallization operating 
parameters e.g. temperature, batch time etc. to enhance/prevent the desired/undesired 
transformations. Early work on SMPT characterization involved sampling of suspension 
at different time intervals to separate the solid and liquid phases and analyze to measure 
the solute concentration and polymorphic composition (Davey et al., 1985; Davey and 
Richards, 1985; Kitamura, 1989; Kitamura, 1993; Maruyama et al., 1999). Offline 
methods such as PXRD, DSC, microscopy and particle size analyzer etc. for polymorphic 
content and UV-Vis, HPLC, etc. for solute concentration measurements have been used, 
respectively. However, due to the dynamic nature of polymorphic transformation and the 
instability of certain polymorphs, offline-analysis is largely affected by sampling errors 
(Yu et al., 2004). Consequently, in line, real time measurements such as PATs would be 
more advantageous. Moreover, real time, in line detection of polymorphs and their 
transformation during crystallization is an asset for process control. Application of PATs 
for in situ monitoring of solute concentration has been discussed before (refer to section 
5.2.2).  The same methods can be employed for SMPT characterization. The following 
discussion emphasizes on PATs for in situ monitoring of polymorphs.  
In the past two decades, a wide variety of PATs have been applied for polymorph 
monitoring (Mangin et al., 2009). Among the many, near-infrared (NIR) and Raman 
spectroscopy are the most prominent because of their distinct advantage of operating in a 
remote manner using fiber-optic waveguides and transflectance probes (Stephenson et al., 
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2001). The potential of fiber optic NIR spectroscopy to quantitatively monitor 
polymorphic composition of a solid-state API during an industrial crystallization process 
has been demonstrated (Fevotte et al., 2004). Recently, Raman spectroscopy has become 
more popular in pharmaceutical research and is the most widely applied technique in 
SMPT studies. Its use for polymorph monitoring in suspensions was first demonstrated 
by Wang et al., (2000) with progesterone as a model system. Similarly, Starbuck et al. 
(2002) used Raman spectroscopy to determine the rate of polymorphic transformation of 
a complex multipolymorphic API, referred to as MK-A. The study of SMPT of pseudo 
polymorphs of citric acid and carbamazepine was also performed using Raman (Caillet et 
al., 2006; Qu et al., 2006).   
As polymorphic changes are often accompanied by a change in morphology, 
alternative techniques such as focused beam reflectance measurement (FBRM) and inline 
video microscopy have been used to monitor polymorphic transformations. FBRM is a 
probe-based particle counter which utilizes laser backscattering technology to measure, in 
real time, a chord length distribution (CLD) which is proportional to particle size 
distribution (O'Sullivan et al., 2003; Yu et al., 2007). In situ video probes such as process 
vision and measurement (PVM) provide in situ high resolution imaging of particles 
within the process environment. Relying on the distinct morphological difference  
between δ and β polymorphs, O'Sullivan and Glennon (2005) successfully monitored the 
polymorphic transformation of D-Mannitol in aqueous solution using FBRM. Similar 
studies can be found in the literature (Barthe et al., 2008; Dang et al., 2009; Liu et al., 
2009). However, these techniques rely on indirect measurements on polymorphs and 
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therefore, the information obtained remains qualitative and often the interpretation is 
difficult.        
5.3. PAT in the Present Work  
The PAT framework used in the present work mainly consists of two process 
analyzers, ATR-FTIR and Raman spectroscopy. They were coupled with chemometric 
techniques and automated for in situ monitoring of crystallization operations. Before 
going into experimental details, the following text introduces the working mechanism of 
these instruments and the coupled chemometric methods.  
5.3.1. ATR-FTIR  
 
Figure 5.1 Working principle of ATR-FTIR (Lewiner et al., 2001). 
 
The working principle of ATR-FTIR is shown in Fig. 5.1 (For theory, refer to 
section 2.5.2). A laser beam generated from the FTIR spectrophotometer is directed by 
optics to the prismatic ATR crystal located at the tip of the probe which is in contact with 
the slurry. Part of the beam is reflected at the ATR crystal/liquid interface. Another part 
propagates into the liquid phase where absorption takes place.  After being reflected back 
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The penetration depth 𝑑𝑝 can be calculated by Eq. 5.1: 
             𝑑𝑝 = 𝜆2𝜋𝑛1[𝑠𝑖𝑛2𝜃 − (𝑛2 𝑛1⁄ )2]1 2⁄                                                                                 5.1 
The refractive index of ZnSe crystal used in this study is, 𝑛1 = 2.4 and 𝑛2 = 1.5 
for water. With 𝜃 = 45° the penetration depth at 𝜆 = 1000 cm-1 is 2 µm.  Such a depth is 
shorter than the boundary layer of laminar flow surrounding the ATR crystal.  Therefore 
the absorbance recorded in the absorbed reflected beam is from the liquid phase in 
immediate contact with ATR crystal only, with minimum interference from the solid 
phase. On occasion, the nucleation process can be observed if the nuclei are smaller than 
a few micrometers, but often the IR absorbance of the particles is weak compared to that 
of the dissolved species. A significant advantage of using ATR-FTIR compared to NIR is 
its measuring range which is mid-IR (400–4000 cm-1) where fundamental vibrations are 
active. Therefore, spectra are less complicated with well-resolved peaks compared to 
NIR. 
5.3.2. Chemometrics for ATR-FTIR 
The most commonly used chemometric methods with ATR-FTIR for relating the 
IR spectra to the solute concentration are partial least squares (PLS) and principal 
component regression (PCR). These methods are based on linear projection of the high 
dimensional spectral data (𝐗) onto the low dimensional latent variable space which 
contains most of the important information. Those underlying features of new data are 
used for regression on to a known solute concentration vector (𝐲) to develop quantitative 
models.  
However, one important issue with online measurements using IR spectra as well 
as any other multivariate data is the presence of 𝐲- unrelated variation in 𝐗 due to 
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external effects such as temperature, sample characteristics, light scattering, instrumental 
drift etc. For example, when ATR-FTIR is used in cooling crystallization, temperature 
varies over a large range which can affect the IR band shapes and such variation is 
unrelated to solute concentration (Wulfert et al., 2000). Similarly, anti-solvent 
interference in anti-solvent crystallization, presence of impurities etc. can vary the IR 
spectrum independent of solute concentration. Such variation is a non-linear phenomenon 
which complicates the linear multivariate techniques like PLS and PCR. Consequently, 
the model is forced to use more regression factors than is to be expected by the chemical 
rank (number of components in the sample). This non-ideal modelling can have adverse 
effects on model interpretability and robustness (Zeaiter et al., 2005). In order to promote 
ATR-FTIR as well as any other spectroscopic technique to real-life industrial 
applications one must consider these issues (Feundale et al., 2002).    
It is a common practice to pre-process 𝐗 to remove the 𝒚- unrelated variation 
before it is subjected to regression modelling. Zeaiter et al., (2005) theoretically proved 
that pre-processing can significantly enhance the model performance and robustness. The 
most commonly used methods are geometrical spectral pre-processing (standard normal 
variate (SNV) transformation, multiplicative scatter correction (MSC), smoothing and 
differentiation) and orthogonal projection. The main drawback of geometrical methods is 
that they are empirical in nature and thus they have the risk of removing the information 
which is relevant to model prediction. Orthogonal projection methods are more logical in 
that they remove only that part from spectra which is linearly unrelated i.e. 
mathematically orthogonal to 𝒚. Therefore, there is little scope for losing relevant 
information. Wold et al. (1998) first introduced this idea by developing orthogonal signal 
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correction (OSC) filters. They also investigated the applicability of OSC to calibration 
transfer to different instruments (Sjoblom et al., 1998). Pollanen et al. (2005) has applied 
OSC to pre-process ATR-FTIR data to develop a stable calibration model for monitoring 
solute concentration in crystallization operations. They found that OSC filtering has 
simplified the model and also enhanced the robustness.  
Subsequently, several authors have presented different OSC algorithms 
(Andersson, 1999; Fearn, 2000; Hoskuldsson, 2001; Westerhuis et al., 2001; Feudale et 
al., 2002; Trygg and Wold, 2002). Svensson et al. (2002) provided a comparison of 
various OSC algorithms and their effectiveness in improving model interpretability and 
performance. Among the many OSC algorithms, orthogonal projection to latent structures 
(OPLS) developed by Trygg and Wold (2002) is unique since it combines the features of 
PLS with orthogonal projection. This hybridization addresses some of the issues associate 
with OSC filters (Wold et al., 1998) which often lead to overfitting and degradation of 
calibration models. In OPLS, OSC filter is built in such a way that it removes only 
variation in 𝐗 explained in each PLS component that is not correlated to 𝒚. One important 
property of OPLS is that, for single 𝒚- variable cases, it will always reduce down to a 
single regression factor, thereby ensures good model interpretability and robustness. In 
the same reference in which OPLS is reported (Trygg and Wold, 2002), an extension 
referred to as OPLS (PCA) which uses principal component analysis (PCA) to remove 
orthogonal information was also presented. In the present work, OPLS (PCA) algorithm 
has been coupled with ATR-FTIR and applied for in situ monitoring of solute 
concentration.  
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5.3.3. Raman Spectroscopy 
Raman spectroscopy has emerged in recent years as ‘one of the fastest, most 
reliable and most suitable technique to identify crystal forms and can be easily exploited 
routinely for monitoring phase changes’ (Auer et al., 2003). Samples for Raman analysis 
may be solids, liquids, or gases, or any forms in between and in combination such as 
slurries, gels etc. Since crystallization is a multiphase phenomenon, Raman spectra will 
be a combination of Raman scattering from both the solids and the solution, with the 
solids dominating due to the greater scattering cross-section. Like ATR-FTIR, Raman 
also operates in mid-IR range, thus greater chemical selectivity with well-resolved peaks. 
 
Figure 5.2 Working principle of Raman Spectroscopy (adapted from Kaiser Optical Systems). 
 
The working mechanism of Raman spectroscopy is described below (For theory, 
refer to section 2.5.2). A typical Raman spectrometer is made up of three basic parts: the 
laser, probe, and the spectrograph (see Fig. 5.2). A laser beam generated in Raman 
spectrophotometer is directed by optics via a fiber to the probe tip which is in contact 
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with the slurry to excite Raman spectra. The probe collects the scattered photons via 
another fiber, filters out the Rayleigh scatter and any background signal from the fiber 
optic cables, and sends the Raman scatter to the spectrograph. In the spectrograph, 
Raman scattered photons pass through a transmission grating to separate them by 
wavelength and passed to a detector, which records the intensity of the Raman signal at 
each wavelength. This data is plotted as the Raman spectrum. 
5.3.4. Raman with Multivariate Statistical Process Monitoring 
The most commonly used chemometric method with Raman for relating the Raman 
spectra to the polymorphic composition is the PLS method. There are several studies 
which reported on quantitative monitoring of polymorphic composition during 
crystallization using PLS modelling (Starbuck et al., 2002; Scholl et al., 2006; Caillet et 
al., 2007; Cornel et al., 2008). Despite the success, there are several issues which 
remained to be addressed. Raman calibration is a time-consuming effort which involves 
preparing standards at different proportions of polymorphs and dispersing in solution to 
collect Raman spectra. If one wants to correct for the temperature effect, the whole 
procedure has to be repeated at different temperatures which is practically less desirable. 
The other issue is the presence of unrelated variation in Raman data which can 
complicate PLS models. Raman intensities are observed to be sensitive to external effects 
such as particle size, suspension density etc. which can vary during the crystallization 
operations. Some improvements have been reported by using pre-processing (Hu et al., 
2006), explicit calibration i.e. modelling the external effects by preparing an extensive set 
of calibration samples (Cornel et al., 2008) and advanced calibration methods (Chen et 
al., 2008). In the present work, multivariate statistical process monitoring (MSPM) has 
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been applied with Raman for polymorph monitoring. An advantage of MSPM is that it is 
completely data-based, therefore, no sophisticated calibration is required to apply these 
techniques. The following text provides more details on MSPM.  
MSPM using latent variable methods, PCA in particular, has been proven very 
useful for on line monitoring, analysis and control of industrial chemical processes 
(Nomikos and Macgregor, 1995; Kourti, 2005). The basis of this approach is to build an 
empirical PCA model of a historical set of on-line batch process data obtained under 
normal operating conditions. New batches are then monitored by collecting samples and 
projecting onto the model to check how good they fit the model. There are several model 
statistics available to evaluate the goodness of fit. In out of control situation, PCA also 
offers a means for a proper investigation for the root cause to the process abnormalities.  
However, use of spectroscopy in MSPM applications is quite rare. The main 
challenge is obtaining a reliable reference data for building a model which is valid over a 
period of time (Gurden et al., 2002). In comparison to engineering data such as 
temperature, pressure, flowrate etc. spectroscopic data are generally more sensitive to 
changes in process conditions such as variation in the background medium, temperature 
fluctuations etc. Recently, Pollanen et al. (2006) has introduced the concept of dynamic 
PCA based MSPM and applied it for monitoring the onset of crystallization process using 
ATR-FTIR. In this approach, a PCA reference model was dynamically built using the 
spectra collected in the undersaturated stage which is called the training period. 
Subsequent spectra were projected on to this model to detect the nucleation event. This is 
called the prediction period. In this way, the uncertainties associated with predefined off-
line reference models were eliminated and MSPM with spectroscopy was achieved. In 
Chapter 5                                                                                 PAT and Experimental Setup 
 
 90 
the present work, we adopted this idea and implemented it with Raman spectroscopy for 
monitoring polymorphs as well as for the detection of the nucleation event.        
5.4. Experimental Section 
5.4.1. Materials  
TB (≥ 98 % purity) was purchased from Junda Pharmaceutical Co.Ltd. (Jiangsu, PR 
China). The PXRD confirms that it belongs to Form IL and used as such without further 
purification. The solvents (ethanol and deionized water) used were of analytical reagent 
grade. A mixed solvent ethanol/water (60:40 w/w) was prepared and used for all the 
experiments. To prepare Form II, Form IL crystals were suspended in excess in solution 
at 30 °C and stirred for 4–5 hours to allow polymorphic transformation. The obtained 
Form II crystals were filtered and dried in vacuum oven at RT. Polymorphic purity was 
verified using PXRD. 
5.4.2. Experimental Setup and Instrumentation 
A schematic diagram of the experimental setup is shown in Fig. 5.3. All the 
experiments were performed in a 1-liter flat-bottomed glass crystallizer with an inner 
diameter of 100 mm. It was fitted with four glass baffles on the inner wall to enhance the 
mixing properties. A marine-type impeller made of stainless steel with a diameter of 42 
mm driven by a variable speed overhead stirrer motor was used to provide agitation. An 
agitation speed of 250 rpm was used which is sufficient to keep the crystals in 
suspension. The temperature in the crystallizer was controlled by a heating and 
refrigerated circulator (Julabo FP50-HL) and measured every 2 s using a Pt100 
thermocouple. 
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IR absorbance spectra were collected with a resolution of 4 cm-1 on a Nicolet 4700 
spectrophotometer (Nicolet Instrument Co.) equipped with a Dipper-210 ATR-FTIR 
immersion probe (Axiom Analytical Inc.). A conical ZnSe crystal is sealed to one of its 
end with two ATR reflections. Every spectrum was the average of 64 scans in the range 
of 600–4000 cm-1. Spectra of ethanol/water (60:40 w/w) solvent at 22 ºC were used as 
background. The FTIR was purged continuously by purge gas supplied by a FTIR purge 












Figure 5.3 Experimental setup for crystallization experiments. 
 
In situ Raman spectra were collected using a Raman Rxn4 analyzer from Kaiser 
Optical System Inc. (Ann Arbor, MI) equipped with an Invictus NIR external cavity 
stabilized diode laser operating at 785.714 nm and 450 mW. The system was equipped 
with single grating f/1.8 holographic imaging spectrograph with a holographic notch filter 

















8. Marine type 
impeller
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Backscattered radiation was collected from the sample via a 1 4�  - in. immersion probe 
sealed with a sapphire window coupled with the spectrometer fiber-optic cable. Raman 
spectra were acquired continuously after an exposure time of 5 s and the average of 5 
accumulations unless otherwise stated. 
In one of the MZW experiments, for a comparison, FBRM probe (Lasentec, model 
D600L) was also inserted along with Raman probe. FBRM chord length distributions of 
the TB crystals were obtained in situ with 10 sec measurement duration using the Control 
Interface Software, version 6.0b16. Data acquired were analyzed using the Data Review 
Software, version 6.0b16, which displays CLD and the corresponding statistics. In few 
experiments, Lasentec PVM probe was inserted to collect in situ images of slurry for 
visual inspection.  
 For off-line polymorphic verification, the slurry was sampled, filtered and dried 
overnight in vacuum oven at RT. PXRD measurements of dried crystals were conducted 
in Bragg-Brentano geometry with a Bruker D8 Advance (Bruker AXS GmbH, Germany) 
X-ray powder diffractometer  equipped with Cu-Kα source ( λ = 1.5406 Å), a Nickel-
filter, 0.3° divergence slit, a linear position sensitive detector (Vantec-1). Data were 
collected at RT over a 2θ range of 5 – 50° with an equivalent step size of 2θ = 0.018° at a 
scan rate of 0.02° sec-1. All samples were rotated to improve the counting statistics. 
 Solid-state Raman spectra of Forms IL, II and III were acquired using a Raman 
microscope (Invia Reflex, Renishaw) equipped with near infrared enhanced deep-
depleted thermoelectrically peltier cooled CCD array detector (576 × 384) pixels and a 
high grade Leica microscope. The Raman scattering was excited with a 50-mW NIR 
diode laser operating at 785 nm. Scans were performed in a spectral window ranging 
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from 100–2000 cm-1 with a sample exposure time of 10 sec and 4 accumulations. 20× 
objective lens was used to examine the sample. 
 For ATR-FTIR calibration modeling, OPLS (PCA) algorithm is implemented into 
PLS toolbox 4.0 (Eigenvector Research, Manson, WA) working under Matlab 7.9 
(Mathworks, Natick, MA). ATR-FTIR calibration and measurement of solute 
concentration were automated using a Visual Basic .NET program that communicates 
with ATR-FTIR and chemometrics. For polymorph monitoring, dynamic PCA based 
MSPM was built in Matlab and automated using Raman/Matlab interface. 
5.4.3. Mathematical Methods  
In the following text, matrices are denoted by bold uppercase letters. Vectors are 
assumed to be column vectors unless indicated by a transposition, for example 𝐱𝐓, and 
denoted by bold lowercase letters. Scalars are denoted by regular lowercase letters.   
For a set of mean centered spectral data matrix 𝐗(𝑛 × 𝑚) with 𝑛 samples and 𝑚 
variables (intensities at wavenumber) and the corresponding concentration vector 𝒚(𝑛 ×1), the latent variable models are given by Eqs. (5.2) and (5.3).  𝐗 = 𝐭𝟏𝐩𝟏𝐓 +  𝐭𝟐𝐩𝟐𝐓 + ⋯+ 𝐭𝐊𝐩𝐊𝐓 + 𝐄 = 𝐓𝐏𝐓 + 𝐄                                                                 (5.2)  𝐲 = q𝟏𝐭𝟏 +  q𝟐𝐭𝟐 + ⋯+ qK𝐭𝐊 + 𝐟 = 𝐓𝐪𝐓 + 𝐟                                                                    (5.3) K is the number of latent variables (LVs). 𝐄 and 𝐟 are the residual matrices, 𝐓(𝑛 × K) is 
the matrix of 𝐗 scores, and 𝐏(𝑚 × K) and 𝐪(1 × K) are the loading matrices of 𝐗 and 𝐲, 
respectively. 𝐭𝐢 and 𝐩𝐢 are the column vectors of 𝐓 and P and qi is a scalar coefficient, 
corresponding to ith latent variable, respectively. Typically, the dimension K is quite small 
compared to the dimension of the original data (K ≪ 𝑚) which is normally determined 
by cross-validation or variance analysis. The loading vectors express how the original 
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variables are weighed together in a corresponding LV and the score vectors contain a 
score value for each spectrum and signify how each sample is related to other in a 
particular LV. Three latent variable methods were employed in this work whose 
mathematical details are described below.     
Principal Component Analysis (PCA). PCA models only single space 𝐗 by finding the 
latent variables called principal components (PCs) that explain the maximum variance 
in 𝐗. Mathematically, PCA relies upon the eigenvector decomposition of the covariance 
matrix (𝐗𝐓𝐗) to extract PCs. The loading vectors (𝐩𝐢) are the eigenvectors of the 
covariance matrix and the corresponding eigenvalues (𝜆𝑖’s) signify the amount of 
variance captured by a given PC. To derive an optimum PCA model, a good rule of 
thumb is to include PCs until the subsequent PC captures <2% variation in 𝜆𝑖’s. The 
corresponding scores vector 𝐭𝐢 is then generated by the linear projection of 𝐗 on to the PC 
space using the loading vector (𝐭𝐢 = 𝐗𝐩𝐢). The unmodeled variation in 𝐗 is considered 
noise and consolidated into the residual matrix 𝐄.  
There are several PCA statistics including the scores itself can be used for MSPM. 
For MSPM, score values for any new sample 𝐱T can be obtained by projecting the sample 
on to directions defined by loadings (ti = 𝐱𝐓𝐩𝐢). Two commonly used PCA statistics are 
T2 and Q statistics. T2 measures the distance of the new sample from the model centre 
within the model space. This determines whether the projected sample has any systematic 
deviation from the steady-state region. Q statistic is complementary to T2 and measures 
the orthogonal distance of the sample from the model space. It is useful in monitoring the 
nonsystematic variations which are not explained by the model. Fig. 5.4 shows the 
geometric interpretation of these statistics for a two-component PCA model. 
Chapter 5                                                                                 PAT and Experimental Setup 
 
 95 
T2 and Q statistics can be calculated by Eqs. (5.4) and (5.5). 
𝑇2 = �𝑡𝑖2
𝜆𝑖
                                                                                                                                   (5.4)K
𝑖=1
 
𝑄 = �(𝑥𝑗 − 𝑥𝚥�)2𝑗=𝑚
𝑗=1
                                                                                                                      (5.5) 
ti is the sample score on ith PC. 𝑚 is the number of variables and 𝑥𝑗 and 𝑥𝚥�  are the 
measured and predicted spectral values of a new sample corresponding to 𝑗𝑡ℎ variable.  
Along with statistics, PCA also allows to extract variable contribution plots which 
show the contribution from individual variables to the calculated statistic. Such a plot is 











Figure 5.4. Geometrical representation of T2 and Q statistics. 
Contributions to Q statistic: 
The difference (𝑥𝑗 − 𝑥𝚥�) is called the variable residual and used for monitoring the 
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Contributions to T2 statistic:  





                                                                                                                                (5.6) 
𝑐𝑗 is the T2contribution of  𝑗𝑡ℎ variable, 𝑡𝑖 is the score value on 𝑖𝑡ℎ PC, 𝑝𝑗𝑖is the loading 
on 𝑖𝑡ℎ PC corresponding to 𝑗𝑡ℎ variable, 𝜆𝑖 is the eigenvalue corresponding to 𝑖𝑡ℎ PC, 
respectively.                                                        
Partial Least Squares (PLS). PLS is a popular latent variable method which can model 
both 𝐗 and 𝐲 data. The objective of PLS is to find LVs that explain both the maximum 
variation in 𝐗 and correlates with the variation in 𝒚. A commonly used PLS NIPALS 
algorithm (see Table 5.1) operates sequentially to extract each LV and the corresponding 
model parameters (𝐰𝐢, 𝐭𝐢, 𝐩𝐢, qi). In this algorithm, a loading weight vector 𝐰𝟏 is 
computed in such a way that it maximizes the covariance between 𝐭𝟏 and 𝐲 (step 2). 
Using standard linear algebra, it can be shown that 
𝐰𝟏 = 𝐗𝐓𝐲‖𝐗𝐓𝐲‖                                                                                                                                 (5.7) 
‖ ‖ is the eucledian norm. The corresponding scores and loading vectors 𝐭𝟏, 𝐩𝟏 and a 
scalar coefficient q1 are then generated (steps 3–5). 𝐰𝟐 is calculated in the same way 
with the deflated forms of 𝐗 and 𝐲, and so on and so forth. 
Mathematically, PLS extracts the eigenvectors of the covariance matrix 𝐗𝐓𝐲𝐲𝐓𝐗 as 
the loading weight vectors 𝐰𝐢. As the true rank of covariance matrix is only one, ideally 
PLS should extract only one 𝐰𝐢. However, the presence of 𝒚- unrelated variation in 𝐗 can 
disturb the extraction and as a result, PLS extracts additional LVs to satisfy the model 
requirements. This increase in model complexity can negatively affect the model 
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robustness and interpretation. To address these issues, the PLS algorithm has been 
modified to build simpler and robust PLS models. 
Table 5.1 Comparison of PLS and OPLS (PCA) algorithms. 
Step PLS OPLS (PCA) 




 𝐰 = 𝐗𝐓𝐲
‖𝐗𝐓𝐲‖
 
3 𝐭 = 𝐗𝐰 𝐭 = 𝐗𝐰 
4 q = 𝐲𝐓𝐭/(𝐭𝐓𝐭) q = 𝐲𝐓𝐭/𝐭𝐓𝐭 
5 𝐩 = 𝐗𝐓𝐭/(𝐭𝐓𝐭) 𝐩 = 𝐗𝐓𝐭/𝐭𝐓𝐭 
6  𝐰𝐨𝐫𝐭𝐡𝐨 = 𝐩 − �𝐰𝐓𝐩𝐰𝐓𝐰�𝐰 
7  𝐭𝐨𝐫𝐭𝐡𝐨 = 𝐗𝐰𝐨𝐫𝐭𝐡𝐨 




𝐗𝐎𝐏𝐋𝐒 = 𝐗 − 𝐭𝐨𝐫𝐭𝐡𝐨𝐩𝐨𝐫𝐭𝐡𝐨𝐓  
For additional orthogonal 
components, return to step 3 and 
set 𝐗 = 𝐗𝐎𝐏𝐋𝐒, otherwise go to step 10 
10  𝐗𝐨𝐫𝐭𝐡𝐨 = 𝐓𝐨𝐫𝐭𝐡𝐨𝐏𝐨𝐫𝐭𝐡𝐨𝐓 
11  Run PCA on 𝐗𝐨𝐫𝐭𝐡𝐨 
 𝐗𝐨𝐫𝐭𝐡𝐨 = 𝐓𝐨𝐫𝐭𝐡𝐨(𝐩𝐜𝐚)𝐏𝐨𝐫𝐭𝐡𝐨(𝐩𝐜𝐚)𝐓 + 𝐄𝐨𝐫𝐭𝐡𝐨(𝐩𝐜𝐚) 
12  𝐗𝐟𝐢𝐥𝐭 = 𝐗𝐎𝐏𝐋𝐒 + 𝐄𝐨𝐫𝐭𝐡𝐨(𝐩𝐜𝐚), now 𝐗𝐟𝐢𝐥𝐭 is the filtered  
data matrix 
13 𝐄 = 𝐗 − 𝐭𝐩𝐓, 𝐟 = 𝐲 − 𝐭q𝐓 
For additional latent variables, 
return to step 2 and 
set 𝐗 = 𝐄 and 𝐲 = 𝐟 
Run PLS using 𝐗𝐟𝐢𝐥𝐭 
 
Orthogonal Partial Least Squares (OPLS) (PCA). OPLS (PCA) is an extension of PLS 
based on NIPALS algorithm with few additional orthogonalization steps included (see 
Table 5.1). 
In OPLS (PCA), 𝐗 is decomposed into three distinct parts, correlated, 𝐲- unrelated 
and residual parts. The model can be written as 
𝐗 = 𝐭𝟏𝐩𝟏𝐓 +  𝐭𝟐𝐩𝟐𝐓 + ⋯+ 𝐭𝐊𝐩𝐊𝐓 + 𝐭𝐨𝐫𝐭𝐡𝐨𝟏𝐩𝐨𝐫𝐭𝐡𝐨𝟏𝐓 +  𝐭𝐨𝐫𝐭𝐡𝐨𝟐𝐩𝐨𝐫𝐭𝐡𝐨𝟐𝐓 + ⋯+ 𝐭𝐨𝐫𝐭𝐡𝐨𝐑𝐩𝐨𝐫𝐭𝐡𝐨𝐑𝐓 + 𝐄= 𝐓𝐏𝐓 + 𝐓𝐨𝐫𝐭𝐡𝐨𝐏𝐨𝐫𝐭𝐡𝐨𝐓 + 𝐄                                                                                         (5.8) 
𝐲 = 𝐓𝐪𝐓 + 𝐟                                                                                                                                  (5.9) 
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𝑅 is the number of orthogonal components (OCs). 𝐓𝐨𝐫𝐭𝐡𝐨 and 𝐏𝐨𝐫𝐭𝐡𝐨 are the 
corresponding 𝒚- orthogonal scores and loading matrices. 𝐭𝐨𝐫𝐭𝐡𝐨𝐢 and 𝐩𝐨𝐫𝐭𝐡𝐨𝐢 are the 
column vectors of 𝐓𝐨𝐫𝐭𝐡𝐨 and 𝐏𝐨𝐫𝐭𝐡𝐨 corresponding to 𝑖𝑡ℎ OC.  
OPLS (PCA) NIPALS algorithm first computes one ordinary PLS component 
(steps 1–5). The obtained 𝐰 and 𝐩 are then used to compute a new weight vector 𝐰𝐨𝐫𝐭𝐡𝐨 
which is part of 𝐩 that remains orthogonal to 𝐰 (step 6). Using standard linear algebra, 
Trygg and Wold (2002) showed that this is equal to 
𝐰𝐨𝐫𝐭𝐡𝐨 = 𝐩 − �𝐰𝐓𝐩𝐰𝐓𝐰�  𝐰                                                                                                          (5.10) 
Using 𝐰𝐨𝐫𝐭𝐡𝐨, the corresponding scores, loadings vectors 𝐭𝐨𝐫𝐭𝐡𝐨 and 𝐩𝐨𝐫𝐭𝐡𝐨 are then 
generated (steps 7 and 8). In step 9, the orthogonal component is removed from 𝐗. If 
further OCs have to be removed, the whole algorithm (steps 3–9) is repeated, including 
the first PLS step but with new 𝐗. Otherwise, the orthogonal variation removed from 𝐗 is 
collected into 𝐗𝐨𝐫𝐭𝐡𝐨 and decomposed using PCA to remove the residual part and added 
back into the new 𝐗 which forms the new filtered matrix 𝐗𝐟𝐢𝐥𝐭 (steps 10–12). Finally, an 
ordinary PLS algorithm is run on 𝐗𝐟𝐢𝐥𝐭 to extract the PLS model parameters (step 13). 
This OPLS (PCA) pretreated PLS model is then used for predictions of new samples. It is 
important to note that the new samples have to be corrected for orthogonal variation 
using OPLS (PCA) model parameters before PLS model prediction (For more details, 
refer to Trygg and Wold, 2002).       
Determination of Number of Latent Variables. Choosing the correct number of LVs into 
the model is critical. Too few LVs mean not all of the variation within 𝐗 explaining 𝒚 has 
been included in the model and predictions of new samples are compromised. Too many 
components in the model mean that irrelevant variation that does not predict 𝒚 (noise) is 
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included in the model, which can result in overfitting problems. Such models can be 
unstable, and although calibration samples fit very well to the model, the predictions for 
new samples are not accurate. Cross-validation is the common method used to determine 
the optimal number of LVs.  
During cross-validation, parts of the calibration set (test set) are left out of 
calculations and the model is built using a certain number of LVs and applied to estimate 
the test set. This procedure is repeated several times for different test sets and the root-
mean-square error of cross-validation (RMSECV) between predicted and known values is 
calculated using Eq. 5.11 to select the number of LVs.  
RMSECVK =     �∑ (𝑦𝑖 − 𝑦�𝑖)2K𝑖=1 𝑛                                                                                           (5.11) K is the number of chosen LVs, 𝑦�𝑖 is the predicted value of sample 𝑖 using a model that 
was built using a set of samples that does not include sample 𝑖. 𝑦𝑖 is the known value of 
sample 𝑖. 𝑛 is the number of calibration samples. The optimal number of LVs is found 
where RMSECV as a function of the number of LVs reaches a minimum.  
There are various cross-validation methods that differ in how the samples are left 
out of the calibration set. In the present work, leave-one-out (LOO), in which each single 
sample in the calibration set is used as a test set, was used. The RMSECV value was 
examined to estimate the optimal number of LVs.  
Determination of Number of Orthogonal Components. For pre-processing based on 
orthogonal projection methods, the number of OCs to be removed is an important 
parameter. The correction may not be effective if too few components are removed. In 
contrast, removal of too many results in erosion of useful signal. The classic way is to 
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adjust this parameter according to RMSECV. In the present work, for OPLS model, OCs 
were removed until the number of LVs reduces down to one. In addition, the following 
statistics were also calculated to assess the model performance. The correlation 
coefficient (R2X) is a measure of how much of the variance in (𝐗) can be explained by the 
model. The cross-validated variance (Q2) explains how much of the variance in 𝐗 can be 
predicted by the model. 
R2X = SStot − SSresSStot                                                                                                                 (5.11) 
Q2 = SStot − PRESSKSStot         where    PRESSK =  �(𝑦𝑖 − 𝑦�𝑖)2n
𝑖=1
                                      (5.12) 
SStot and SSres are the sum of squares of measured data and model residuals, 
respectively. PRESSK is the cumulative predicted residual sum of squares (PRESS) 
corresponding to Kth LV.  
5.4.4. Experimental Procedures  
ATR-FTIR Calibration Experiments. Different solute concentrations of TB in 400 g of 
solvent (Table 5.2) were placed in the crystallizer and heated until all of the crystals 
dissolved. The solution was cooled at 0.5 °C/ min, while the IR spectra were collected at 
30 sec interval. The measurements were stopped once crystals started to appear by 
observing with naked eye.  
ATR-FTIR Calibration Modeling. The calibration experiments resulted in a data set of 
234 IR spectra collected from various TB concentrations. The IR spectra in the range 
1000–1650 cm-1 were used to construct the calibration model. The higher (2800–3500 
cm-1) and lower (650–1000 cm-1) wavenumber regions are excluded because of large 
frequency shifts with temperature which can make the model unstable. As an example, 
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the raw IR spectra collected for Cs3 in the selected range are shown in Fig. 5.5(a). A 
clear temperature effect and base-line variations independent of solute concentration were 
visible in the spectra. 





Temperature range  
(deg C) 
Number of spectra  
collected 
Cs1 19.8 35 – 14.8 54 
Cs2 48.9 40 – 21.1 61 
Cs3 100.2 50 – 32.5 36 
Cs4 150.4 50 – 38.1 25 
Cs5 190.7 60.7 – 45.3 33 
Cs6 226.7 60.1 – 48 25 
  
Using the calibration set, PLS and OPLS (PCA) regression were applied and the 
resulted models were summarized in Table 5.3. The cross validation suggests a 7- LV 
model for PLS with RMSECV value of 0.23 mg/g. PLS extracts the first LV explaining 
93% variation in 𝐗 that correlates with 99% variation in 𝐲 with RMSECV value of 3 
mg/g. This low correlation can be attributed to the presence of orthogonal 𝐲- unrelated 
variation in IR spectra. As a result, PLS uses another 6 LVs to extract all the 𝐲- related 
variation in 𝐗 to improve the correlation. In OPLS (PCA), the data was pre-processed to 
remove 6 OCs to build a PLS model. The filtered spectra are shown in Fig. 5.5(b) for 
Cs3. OPLS (PCA) has effectively removed the temperature effect and base-line 
variations. This has significantly improved the covariance in calibration data and as a 
result PLS model achieves the optimum correlation with only 1 LV (see Table 5.3). 
Fig. 5.6 shows the comparison of regression coefficient vectors of 7- LV PLS 
model with OPLS (PCA) pretreated PLS model. The similarity of the regression vector of 
OPLS (PCA) model with the original IR raw spectra clearly suggests that the model is 
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free from 𝒚- unrelated variation. On the other hand, PLS regression vector is significantly 
changed particularly in 1000–1200 cm-1 region. It would be interesting to see which 























Figure 5.5 ATR-FTIR raw calibration spectra (Cs3) (a) without pre-processing (b) 6 orthogonal 
components removed using OPLS (PCA). 
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Table 5.3 ATR-FTIR calibration model summary for solute concentration measurements. 
Ordinary PLS model  Orthogonal PLS (PCA) 
LV aR2Xcum bQ2cum RMSECV (mg/g)  LV R
2Xcum Q2cum RMSECV (mg/g) 
1 93.54 99.83 3.02  1 99.99 100 0.23 
2 96.99 99.87 2.66      
3 99.85 99.92 2.04      
4 99.94 99.97 1.35      
5 99.98 99.98 1.15      
6 99.98 99.99 0.53      
7 99.99 100 0.23      

















Figure 5.6 Comparison of regression coefficient vectors of PLS model and OPLS (PCA) 
pretreated PLS model. 
 
Fig. 5.7 shows the principal orthogonal loadings extracted from variation removed 
from IR spectra. First two loadings explain 97 % of orthogonal variation removed and 
represent the temperature effect on IR spectra. It should be noted that the major 
contributions to temperature induced 𝒚- unrelated variation is from 1020–1110 cm-1 and 
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1145–1185 cm-1. This explains why PLS regression vector significantly changed in 
1000–1200 cm-1 region. The third loading explains 2% of orthogonal variation removed 
and represents the baseline variation. Though, OPLS (PCA) removed the 𝒚- unrelated 
information in the form of 6 OCs from the spectral data, it does not improve the model 
predictability since both models gave the same RMSECV value. However, the resulted 

















Figure 5.7 Plot of the 3 principal orthogonal loadings (𝐩𝐨𝐫𝐭𝐡𝐨 (𝐩𝐜𝐚)) removed from IR calibration 
spectra. The corresponding variation captured is 𝐩𝟏𝐨𝐫𝐭𝐡𝐨𝟏 (𝐩𝐜𝐚) (93.56%), 𝐩𝐨𝐫𝐭𝐡𝐨𝟐 (𝐩𝐜𝐚) (3.56%), 
𝐩𝟑𝐨𝐫𝐭𝐡𝐨 (𝐩𝐜𝐚) (1.96%).  
      
Solubility Measurements. Solubilities of TB polymorphs (Forms (IL, IH) and II) were 
measured in the chosen solvent by two different methods in the temperature range of 20 – 
55 °C. For all measurements, a 400 g of solvent was used. In the first method, an excess 
amount of corresponding polymorph was added to the solvent which was maintained at a 
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constant temperature and solute concentration was monitored using ATR-FTIR. As the 
concentration reaches a plateau, spectral measurement was stopped and the solution was 
allowed to settle for 1 hour to collect a sample from the supernatant for gravimetric 
measurements. At the end of each measurement, the suspension was filtered to collect the 
solid and polymorphic form was verified using PXRD.  
In the second method, a saturated suspension of TB was prepared at 20 °C and 
heated in two segments. Below 30 °C, at a heating rate of 2 °C/h and above 30 °C, at a 
heating rate of 3 °C/h. The heating rate is chosen such that it is slow enough to keep the 
suspension in thermodynamic equilibrium and a continuous solubility curve can be 
measured. Intermittently, crystals were added to the solution to keep it in a suspension 
state. Solution concentration was monitored using ATR-FTIR. In the case of Form (IL, 
IH) the measurement was disturbed by polymorphic transformation to more stable Form 
II.  Therefore, its solubility curve was measured in 2.5 hour intervals. After each interval, 
the measurement was stopped to drain the vessel contents and vessel was washed 
thoroughly with the solvent and a fresh batch was started again.   
Solution Mediated Polymorphic Transformation Experiment. A saturated solution (36 
mg/g solvent) of Form IL was prepared at 25 °C with 400 g of solvent. Then, 2.07 g of 
Form IL crystals were suspended in excess which corresponds to 0.5% suspension 
density. The suspension was stirred at 250 rpm while the solution concentration was 
measured using ATR-FTIR. To monitor the polymorphic changes, Raman spectroscopy 
was coupled with MSPM.  
Fig. 5.8 shows the Raman spectra of solvent, solute and different TB crystal forms 
(Forms IL, II and III) in the wavenumber range of 600–1800 cm-1. The major differences 
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between the three polymorphs were apparent in the aromatic ring deformation (785–825 
cm-1) and asymmetric stretching of sulfonyl group (1135–1190 cm-1) regions of TB 
molecule with strong Raman scattering and no overlap with solvent peaks. Therefore, this 
wavenumber region is selected for MSPM. To implement MSPM, a PCA-based reference 
model was built dynamically using the first 30 Raman spectra in the training period. The 
reference data was assumed to be free from abnormalities and number of spectra was 
chosen such that it captures enough variation for building a model. In the prediction 
period, samples were projected on to the model to estimate the corresponding T2 and Q 

















Figure 5.8 Raman spectra of ethanol/water (60:40 w/w), TB solute and crystal forms of TB in the 
wavenumber range of 600–1800 cm-1. 
 
Metastable Zone Width Measurements. Different saturated solutions corresponding to 
Form II were prepared by dissolving known amounts of TB in 400 g of solvent. To 
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ensure complete dissolution, the solutions were heated to 5 °C above the saturation 
temperature and kept constant for 30 min. The solution was then quickly cooled (0.5 
°C/min) to the corresponding saturation temperature and held there for another 30 min. 
Subsequently, the solutions were cooled at different cooling rates (1, 0.5 and 0.1 °C/min) 
with constant stirring (250 rpm). The Raman spectral acquisition was started immediately 
after the solution stabilizes at the corresponding saturation temperature.  
For MSPM, in the training period, a PCA-based reference model was built 
dynamically using the first 30 Raman spectra in the wavenumber range of 600-1200 cm-1. 
In the prediction period, spectra were projected to estimate T2 and Q statistics and their 
variable contributions. The temperature corresponding to a sharp dip in T2 statistic (due to 
explosive nucleation of crystals) was read as the nucleation temperature. For each 
measurement, the experiment was repeated twice and the average temperature was noted. 
Q contribution plots were diagnosed to detect the polymorph nucleated. At the end of 
each experiment, the solution was filtered and crystals were harvested, dried in vacuum 
oven at RT and analyzed using PXRD to verify the polymorph nucleated. 
Batch Crystallization Experiment. An undersaturated solution of TB at 55 °C was 
prepared by dissolving a known amount of TB in 400 g solvent corresponding to the 
solubility of Form II at 50 °C. The solution was then cooled at 0.08 °C/min. ATR-FTIR 
was used to continuously monitor the solute concentration. PVM probe was also inserted 
to collect the slurry images for visual inspection. The obtained crystalline product was 
filtered, dried in vacuum oven at RT and subjected to PXRD to verify the polymorphic 
purity.





Crystallization Process Development for the Isolation of 
Desired Form of Tolbutamide 
  
  
 In this chapter, using the experimental setup described in chapter 5, a cooling 
crystallization process was developed for the isolation of the desired form of TB. QbD 
based strategy described earlier was applied by determining a design space in terms of the 
metastability of the desired form. A crystallization batch process was successfully 
operated to achieve the desired polymorph.   
6.1. Selection of the Desired Form of TB 
For the production of TB, Form II is the ideal form to select because it is 
thermodynamically most stable and has the lowest propensity for polymorphic 
transformation. However, its innate characteristic of crystallizing in a thin fiber needle 
shape (refer to Fig. 4.16a) is a major obstacle for its downstream processing such as 
filtration, drying etc. It has also been observed that Form II has the least tendency to 
nucleate directly from the solution. Therefore, a metastable form is a viable option for 
this system. In the hierarchy of stability of TB polymorphs, the next stable form is Form 
(IL, IH) which also has good processability characteristics. Therefore, in the present work, 
this polymorph has been chosen as the desired form for the crystallization of TB.    
6.2. Solubility Measurements of TB Polymorphs  
The solubility curves of Forms (IL, IH) and II are shown in Fig. 6.1. The 
continuous nature of solubility of Form (IL, IH) with respect to temperature in the region 
of 39–41 °C clearly suggests that the equilibrium conditions were prevailed during the 
measurements. Otherwise, we would have observed a dip in concentration in this region 
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due to the delay in dissolution caused by the solid-state transformation of Form IL → IH 
(Kawakami, 2007). The concentrations measured using ATR-FTIR showed good 
agreement with the solubility data obtained using gravimetric method validating the 
calibration model built using OPLS (PCA). These measurements also suggest that Form 
II is more stable than Form (IL, IH) in this temperature range which agrees with our 
earlier characterization studies (Thirunahari et al., 2010).  
    
Figure 6.1 Solubility curves of TB Forms (IL, IH) and II in ethanol/water (60:40 w/w). 
 
6.3. Statistical Monitoring of Polymorphic Transformation 
As discussed earlier, SMPT is the main mechanism by which metastable 
polymorphs undergo transformation during crystallization. Since the desired polymorph 
of TB is metastable in nature, it may undergo transformation to the more stable Form II. 
Therefore, characterization of transformation kinetics is essential to understand the 
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fundamental mechanisms governing the process. Such information is useful to determine 
optimum operating conditions for crystallization to prevent the transformation. To this 
aim, a seeded polymorphic transformation experiment was performed during which 
polymorphic content was monitored using Raman spectroscopy and solute concentration 
was monitored using ATR-FTIR.    
Fig. 6.2 displays the time resolved Raman spectra collected in the selected 
wavenumber range during the seeded transformation experiment. As we can see, as time 
progressed, in 785–825 cm-1 region (Fig. 6.2(a)), the characteristic peaks of Form IL at 
798 and 812 cm-1 decreased in intensity. Towards the end, the peak at 812 cm-1 becomes 
a shoulder peak which is a characteristic of Form II. In 1140–1190 cm-1 region (Fig. 
6.2(b)), the peak at 1161 cm-1 gradually shifted to 1164 cm-1 which is a characteristic 
peak of Form II. These observations suggest that Raman spectroscopy is capable of 
detecting the polymorphic changes in TB crystals in suspensions. However, for a 
mechanistic understanding, the dynamic PCA based MSPM was applied with Raman 
which is discussed below. The main advantage of MSPM is that it decouples the spectral 
variations caused by stable and metastable forms, thus making the interpretations much 
easier. 
For dynamic PCA based MSPM with Raman, a reference PCA model was built in 
the training period which resulted in a two component model with PC1 capturing 89.9% 
and PC2 capturing 2.2% variation. Subsequent PCs were ignored and added into the 
model residual space because they capture negligible variation (< 2%). PC1 can be 
directly related to Form IL, since the corresponding loadings of PC1 are similar to the 
spectral features of Form IL. Physical interpretation of PC2 is difficult, but may be 
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attributed to the effect of particle size of Form IL crystals on Raman scattering. In the 



























Figure 6.2 Time resolved Raman spectra for a seeded polymorphic transformation of TB Form IL 
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6.3.1. T2 and Q Plots  
 
Figure 6.3 T2 and Q statistic plots for a seeded polymorphic transformation of TB Form IL to II. 
 
Fig. 6.3 shows the T2 and Q statistic plots with respect to time. As stated earlier 
(refer to section 5.4.3), T2 measures the systematic variation within the model space, 
therefore it refers to the variations occurring in the metastable form, Form IL. On the 
other hand, Q statistic measures the unmodeled variation and therefore it refers to the 
new variations brought about by the transformation into the process i.e. those variations 
related to the stable Form II. In Fig. 6.3, initially, both statistics were within the 95% 
confidence limit imposed by the model indicating that no variation in the suspended 
Form IL crystals. After 200 min, both statistics crossed the limit and moved away from 
the reference. This indicates that the polymorphic transformation of Form IL has been 
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triggered. Towards the end of the experiment i.e. after 300 min or so, both were stabilized 
at a higher value suggesting the end of transformation. 
To verify these interpretations, the variable contribution plots of T2 and Q were 
inspected. Fig. 6.4 shows the T2 and Q contribution plots. Here, the variables are the 
Raman intensities at different wavenumber. For T2 contribution calculations, only PC1 
was used as it captures the major portion of variation. The arrows shown indicate the 
direction of the contribution with respect to time.  
As we can see, the major contributions to T2 value during the transformation are 
from the Raman intensities corresponding to 798 and 810 cm-1 in 785–825 cm-1 region 
and 1161 cm-1 peak in 1140–1190 cm-1 region which are characteristics peaks of Form IL. 
The arrows indicate that these contributions are decreasing with respect to time 
suggesting that Form IL crystals are undergoing dissolution. In Q contribution plots, the 
major contributions to Q value in 785–825 cm-1 region are from 798, 811 and 817 cm-1. 
The arrows indicate that the contributions from 811 and 817 cm-1 are decreasing with 
respect to time. This is consistent with Raman characteristics of Form II, for which there 
is a shoulder peak in this region. On the other hand, a major contribution from 1140–
1190 cm-1 region is from 1164 cm-1 which is a characteristic of Form II which increases 
with time. All these Q contributions clearly suggesting that the jump in Q value is due to 
the nucleation and growth of Form II.  
There are a few other contributions, particularly to Q value, which may be due to 
the unrelated variation gathering in the Raman spectra during the transformation due to 
change in particle size, suspension density etc. However, contribution plots clearly 
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provided the evidence that the increase in T2 and Q values is due to polymorphic 
transformation. 
 
Figure 6.4 Variable contribution plots of T2 and Q in the selected wavenumber range (A) 785–
825 cm-1 and (B) 1140–1190 cm-1. 
 
6.3.2. Identification of the Rate Controlling Step  
As described earlier in chapter 2, a polymorphic transformation can be controlled 
by any of the three steps; primary nucleation of the stable form or dissolution of the 
metastable form or growth of the stable form. This information can be derived by 
comparing the time profiles of solid and liquid phase composition during the 
transformation. For this purpose, the time profiles of T2 and Q were converted into 
polymorph composition profiles of Form IL and Form II, respectively. To achieve this, T2 
and Q values were uniformly scaled such that the maximum values of T2 and Q become 
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equal to 0% of Form IL and 100% of Form II, respectively. Fig. 6.5 shows the time 
profiles of Form IL and Form II compositions along with the solute concentration profile 
measured using ATR-FTIR. 
Figure 6.5 Time profiles of solute concentration and polymorph composition of TB during 
seeded polymorphic transformation at 25 °C in ethanol/water (60:40 w/w) solvent. To get the 
polymorphic composition, T2 and Q values were uniformly scaled such that the maximum value 
equal to 0% Form IL and 100% Form II respectively. 
 
In Fig. 6.5, during the initial period of 200 min, solute concentration remained at 
the solubility of Form IL. This period is the induction time of Form II during which 
solute molecules undergo molecular recognition processes to build Form II clusters. 
Upon reaching the limit, Form II nucleates from the solution causing the solute 
concentration to drop below the solubility of Form IL. Accordingly, solid composition of 
Form II increases. This simultaneously triggers the dissolution and growth phases of 






































 Solubility of Form II
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Form IL and II, during which solution was supplied with more solute molecules from 
dissolution of Form IL, decreasing its solid composition. These molecules are transferred 
on to the growing Form II crystals increasing its solid composition.  
During this phase, if the dissolution is faster than growth, solute molecules 
accumulate and the solute concentration remains closer to the solubility of Form IL. If the 
growth is faster than dissolution, solution is depleted out of solute molecules and solute 
concentration remains closer to the solubility of form II. But here neither case happened. 
The solute concentration continuously decreased after the nucleation of Form II 
indicating that both the dissolution of Form IL and growth of Form II are equally fast. 
This phase is continued for another 90 min or so until all the Form IL crystals dissolved. 
By that time, solute concentration has almost reached the solubility of Form II and the 
remaining little supersaturation is quickly consumed by further growth of Form II and 
transformation is ended. This analysis clearly suggests that the rate controlling step for 
the transformation process is neither the dissolution of Form IL nor the growth of Form 
II. It is the primary nucleation of Form II which is controlling the transformation. 
However, towards the end, the rate of transformation is decreased as evident from 
the decrease in slope of solid composition profiles. This can be attributed to the 
morphology of Form II crystals which drastically changed the fluid dynamics of the 
vessel and vessel contents became stagnant towards the end of the transformation. For 
better evidence, a separate experiment was performed under similar experimental 
conditions with PVM inserted in the crystallizer to collect slurry images during the 
polymorphic transformation. Fig. 6.6 shows the PVM images. After 230 min, which 
corresponds to the initial phase of transformation, the crystals were observed to be freely 
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floating in the vessel. But, after 270 min i.e. towards the end of transformation, Form II 
crystals filled the entire vessel and vessel contents became stagnant. This could affect the 
rate of mass transfer and thereby decreasing the rate of transformation.   
      
     
Figure 6.6 PVM images of TB crystals during the seeded polymorphic transformation at 25 °C in 
ethanol/water (60:40 w/w) solvent (a) Seeded Form IL crystals (b) Form II nucleated and floating 
in the crystallizer (c) Towards the end of transformation, Form II crystals filled the entire vessel 
and vessel contents became stagnant.   
 
6.4. Metastable Zone Width Measurements.  
For MZW measurements, the technique of dynamic PCA based MSPM was 
combined with Raman to detect the onset of nucleation for a variety of saturated solutions 
of TB and cooling rates. In these experiments, the exposure time of Raman spectral 
acquisition was reduced from 5 sec to 2 sec to decrease the sampling period to increase 
its nucleation detection ability. Moreover, a wider Raman wavenumber range was used 
spanning 600–1200 cm-1 which includes the solvent peaks to account for their sensitivity 
to nucleation.  
6.4.1. Determination of Nucleation Temperature  
As an illustration, results obtained for an experiment performed at an initial 
concentration of 109 mg/g solvent corresponding to a saturation temperature of 45 °C and 
a cooling rate of 0.1 °C/min are shown here. For this experiment, the dynamic PCA 
t = 0 min t = 230 min t = 270 min 
 
a b c
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reference model built in the training period resulted in a two component model with PC1 
capturing 88.5 % variation and PC2 capturing 2.1 % variation. PC1 can be directly 
related to the solution phase since the corresponding loadings are similar to the spectral 
features of solution. Interpretation of PC2 is difficult, possibly another independent 
variation in the solution phase. In the prediction period, Raman spectra were projected on 
to the model to estimate T2 and Q statistics. 
 
Figure 6.7 T2 and Q statistic plots of Raman spectra collected in a MZW experiment conducted 
with an initial concentration of 109 mg/g solvent and 0.1 °C/min cooling rate. 
 
Fig. 6.7 shows the T2 and Q statistic plot against temperature. Here, T2 refers to the 
systematic variation occurring in the solution phase while cooling whereas Q refers to the 
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suggests that initially, both statistics were within the 95% confidence limit imposed by 
the model indicating that no variation in the solution. However, T2 and Q stay only for a 
short period of time and move out of the limit and keep moving away in a linear fashion. 
As the nucleation is approached, T2 sensed the event by a dip in T2 values followed by a 
rapid increase. On the other hand, Q statistic senses the event by a higher variation 
followed by a rapid change. 
Figure 6.8 T2 and Q contribution plots of Raman spectra collected in a MZW experiment 
conducted with an initial concentration of 109 mg/g solvent and 0.1 °C/min cooling rate. 
 
To verify these interpretations related to the sensitivity of T2 and Q statistics to 
nucleation phenomena, the T2 and Q contribution plots are shown in Fig. 6.8. In Fig. 6.8, 
the major contributions to T2 value during the cooling are from Raman intensities of 
solvent peaks (882, 1049 and 1090 cm-1) and solute peak (1161 cm-1) which increased 
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with time. This explains why T2 value increased before the nucleation. The increase in 
Raman intensity can be attributed to the increase in solution density upon cooling due to 
reduction in volume of the solution (Hu et al., 2005). However, after a while, T2 
contributions suddenly dropped and decreased to zero and then decreased further in the 
negative region. This variation is reflected in the T2 value which initially decreased in its 
value in Fig. 6.7 as the contributions decreased and then increased as the contributions 
decreased further in the negative region. The sudden decrease in Raman contributions can 
be attributed to the fact that crystallization tends to reduce Raman intensity because a 
solution containing crystals is more opaque than the corresponding transparent solution 
containing molecular clusters prior to formation of crystals. Therefore, it is appropriate to 
measure the point at which T2 value showed a dip (this corresponds to the sharp decrease 
in Raman intensity) as the start of nucleation and the corresponding temperature as the 
nucleation temperature. 
On the other hand, Q contributions during cooling are minor and within the noise 
level, therefore, are not shown here. Possibly, the increase in Q value across the limit 
before the nucleation is due to these minor Raman contributions. However, after the 
nucleation, Raman contributions were increased as shown in Fig. 6.8. As we can see, the 
major Q contributions are from 785–825 cm-1 and 1140–1190 cm-1 which are the 
characteristic regions of TB polymorphs. This explains why Q value increased rapidly 
after nucleation. 
Fig. 6.9 provides a comparison of time profiles of a more conventional FBRM 
measurement during the MZW experiment with Raman based T2 statistic. FBRM detects 
the nucleation event by measuring the increase in particle counts. As we can see from 
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Fig. 6.9, both techniques detected the nucleation event at the same time. However at the 
point of nucleation, FBRM counts were increased whereas Raman based T2 statistic 
decreased due to decrease in Raman scattering because of increase in solution opacity. In 
detecting the nucleation event, Raman has an additional advantage that it can distinguish 
the solid nucleated which is discussed in detail in the next section.   
 
Figure 6.9 Comparison of time profiles of FBRM total counts and Raman based T2 statistic for 
detecting the nucleation event in the MZW experiment conducted with initial concentration of 
109 mg/g solvent and 0.1 °C/min cooling rate. 
 
6.4.2. Detection of the Type of Polymorph Nucleated    
To identify the type of polymorph nucleated during the MZW experiments, PXRD 
measurements were performed. These results suggest that two types of polymorphs of TB 
(Form IL (characteristic PXRD peaks; 12.1° and 13.1°) and Form III (characteristic 
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PXRD peaks; 11.3° and 12.4°)) were crystallized in MZW experiments. Some 
experiments also resulted in a mixture of these two forms. 
However, the polymorphic information can be directly extracted from raw Raman 
spectra. Moreover, we observed that T2 and Q contribution plots are more revealing and 
informative than the corresponding raw Raman spectra as they contain Raman 
contributions exclusively from the solution and the solid phase. For illustration, three 
selected MZW experiments (A,B,C) carried out at same initial concentration (109 mg/g 
solvent) but different cooling rates which resulted in different polymorphic outcome were 
considered here. The corresponding PXRD patterns were provided in Fig. 6.10. Fig. 6.11 
shows a comparison of the raw spectra collected in experiments A, B and C, in the 
wavenumber range of 1130–1190 cm-1, at the time of nucleation with the corresponding 
T2 and Q contribution plots.  
Figure 6.10 Comparison of PXRD patterns obtained for three MZW experiments A, B and C 
which resulted in different polymorphic outcomes of Form IL, III and their mixture, respectively. 
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Experiment A resulted in the nucleation of Form III.  In Fig. 6.11, Raman detects 
the nucleation event by a rapid decrease in intensity at 1161 cm-1 which is a characteristic 
peak of the solute followed by a significant shift in the baseline with two new peaks 
arising at 1146 and 1163 cm-1 which are characteristic of Form III. The corresponding T2 
and Q contribution plots clearly decoupled these variations into contributions from 
solution and Form III crystals. A sharp decrease in T2 contributions from positive to a 
negative value within a span of one sample interval suggests that the nucleation rate of 
Form III is very high. Contributions to Q value clearly magnified the Raman 
characteristics of Form III which increased as crystals continue to grow facilitating the 
identification of type of polymorph nucleated. 
Figure 6.11 Comparison of raw Raman spectra and T2 and Q contribution plots for three different 
MZW experiments in which three different polymorphic outcome obtained (A) Form III (B) 
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Experiment B resulted in the nucleation of Form IL. Raman detects the nucleation 
event by a decrease in intensity at 1161 cm-1 which is a characteristic peak of both the 
solute and Form IL. Upon nucleation, T2 contributions were decreased slowly suggesting 
that the nucleation rate of Form IL is low compared to Form III.  In this case, on the 
contrary, Q contributions decreased with time suggesting that there are no new 
contributions to Raman spectra from Form IL crystals. Probably, the decrease in Q 
contributions is due to the continuous shift in baseline as more and more Form IL crystals 
formed which is reflected as a new change in the process upon nucleation. This is typical 
to Form IL and consistently observed whenever Form IL nucleated. 
Experiment C resulted in the nucleation of a mixture of Form III and Form IL. As 
we can see, a mixed behavior of experiments A and B was observed in the Raman spectra 
and the corresponding T2 and Q contribution plots, suggesting the nucleation of both 
Forms IL and III. However, one can clearly see in Q contribution plot, the first nucleated 
form is Form IL followed by the nucleation of Form III. 
6.4.3. Crystallization Design Space 
Fig. 6.12 shows the MZW measurements along with the solubility curves 
measured for TB-ethanol/water system. The corresponding polymorph nucleated was also 
shown. It should be noted that under the tested experimental conditions, nucleation of 
Form II is not observed. In Fig. 6.12, three domains (D1, D2 and D3) unique to each 
polymorph can be identified. In domain D1, sufficiently fast cooling rate and all initial 
concentrations favored the nucleation of Form III. In domain D2, sufficiently slow 
cooling rate and all initial concentrations favored the nucleation of Form (IL, IH). In 
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domain D3, intermediate cooling rates and all initial concentrations favored the nucleation 
of a mixture of both these forms.  
 
Figure 6.12 Design space for the isolation of Form (IL, IH) in terms of its metastability. 
 
Fig. 6.12 suggests that at constant concentration, nucleation energy barrier 
increases with increase in cooling rate as seen from the increase in MZW. On the other 
hand, at constant cooling rate, nucleation energy barrier decreases with increase in 
concentration. CNT suggests that if the energy barrier increases, the nucleation rate (𝐽) 
increases and vice versa. Therefore, one can expect that the cooling rate and initial 
concentration have an effect on nucleation kinetics of Forms (IL, IH) and III. Two 
important kinetic contributions to nucleation rate are interfacial energy (γ) and 
preexponential factor (𝐴). Faster cooling rate might have promoted the nucleation of 
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Form III by favoring  𝐽𝐼𝐼𝐼 > 𝐽𝐼𝐿 with conditions γ𝐼𝐼𝐼 < γ𝐼𝐿 and 𝐴𝐼𝐼𝐼 > 𝐴𝐼𝐿. On the other 
hand, slower cooling rates might have promoted the nucleation of Form (IL, IH) by 
favoring  𝐽𝐼𝐿 > 𝐽𝐼𝐼𝐼 with conditions γ𝐼𝐿 < γ𝐼𝐼𝐼 and 𝐴𝐼𝐿 > 𝐴𝐼𝐼𝐼. When intermediate cooling 
rates were used, the balance of these contributions to nucleation rates of Forms IL and III 
might have favored the condition   𝐽𝐼𝐿 = 𝐽𝐼𝐼𝐼 and promoted the nucleation of both forms.  
Nevertheless, this analysis clearly suggests that the design space for the isolation 
of desired form of TB is D2 where primary nucleation of Form (IL, IH) is guaranteed.     
6.5. Design and Operation of Selective Crystallization 
Figure 6.13 Desupersaturation profile measured using ATR-FTIR during batch crystallization 
while operating in the design space. Run 1: 0.08 °C/min cooling rate and 250 rpm stirring rate; 
Run 2: 0.08 °C/min cooling rate and 400 rpm stirring rate. 
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For selective crystallization, a cooling crystallization process was designed to 
operate within the design space. However, one possibility which cannot be ignored while 
operating in the design space is the primary nucleation of more stable Form II via SMPT. 
To prevent any possibility of undesired SMPT to Form II, crystallization should be 
designed such that the total crystallization time (excluding the induction time) should be 
within the induction period for the nucleation of Form II (~200 min). Keeping this in 
mind, a process was designed with a saturated solution corresponds to a temperature of 
50 °C which is cooled at 0.08 °C/min until 25 °C. 
Fig. 6.13 shows the desupersaturation profile measured using ATR-FTIR during 
the crystallization operation for runs 1 and 2. In run 1, a hump in concentration profile in 
the region of 39–41 °C which is due to the solid state transformation of Form IH → IL 
clearly indicates that the desired form has been achieved. However, as the crystallization 
proceeds, the stirring rate of 250 rpm was no longer sufficient to keep the growing 
crystals suspended and the crystals started to settle at the bottom of the crystallizer. 
Solute concentration would be lower around the crystals as the solute was continually 
incorporated into the crystals. A concentration gradient thus formed in the crystallizer 
with the lower concentration at the bottom and higher concentration at the top where the 
ATR probe was located. Therefore, the desupersaturation profile appeared to steer away 
from the solubility curve. Run 2 was performed by increasing the stirring rate from 250 to 
400 rpm. Now, the drift was suppressed and a desupersaturation profile with decreasing 
supersaturation was obtained. However, as we can see, increase in stirring rate decreased 
the MZW. Fig. 6.14 shows the PVM image of crystals obtained. The prismatic 
morphology typical of Form (IL, IH) further confirms that the desired form was achieved. 
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Hence, a robust crystallization process for the production of the desired form of TB has 














Figure 6.14 PVM image of Form IL crystals obtained during batch crystallization operation. 
6.6. Summary 
 A crystallization design space for the isolation of the desired polymorph Form (IL, 
IH) of TB has been determined and a crystallization batch process was operated within 
the design space to achieve the desired form. QbD based strategy not only assisted in 
developing a robust process but also provided a good understanding about the 
crystallization behavior of TB. Characterization of polymorphic transformation of TB 
polymorphs Form IL→ Form II suggests that the primary nucleation of the stable Form II 
is the controlling step for the transformation. MZW measurements indicate that the 
cooling rate has a strong influence on the nucleation energy barrier and can be used as a 
manipulator for achieving different TB polymorphs. 
 This work also demonstrates the application of two PATs, ATR-FTIR combined 
with OPLS (PCA) and Raman with MSPM in crystallization process characterization and 
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monitoring. OPLS (PCA) ensures the robustness of the calibration models which is 
particularly important in industrial environments where process disturbances are not 
uncommon. MSPM can be combined with Raman and used as a PAT tool for the 
characterization of polymorphic transformations and nucleation experiments with 
additional advantage of in situ detection of type of polymorph nucleated. The most 
appealing part of MSPM is that it is calibration free therefore it can reduce the 
experimental effort thereby speed up the process development. 
  





CONCLUSIONS AND SCOPE FOR FUTURE WORK 
  
 
Toward a robust crystallization process development for a specific polymorph, an 
understanding of the fundamentals of polymorphism and the role of crystallization 
mechanisms on crystal formation and transformation is essential. With this objective, 
crystallization of tolbutamide (TB), a polymorphic drug, was investigated in this work. 
The main findings are briefly reviewed herein. 
7.1. Significant Contributions 
7.1.1. Structural Origin of Polymorphism in TB 
The conformational flexibility of the TB molecule and strong hydrogen bonding 
ability of secondary amide via carbonyl and sulfonyl groups facilitate TB to crystallize 
into different polymorphic forms (Forms (IL, IH) and II–IV). The rich torsional freedom 
available for the terminal alkyl chain mainly assists TB molecule to adopt various 
conformers and crystalline packing arrangements. By elucidating the crystal structures of 
various polymorphic forms of TB, the present work resolves several discrepancies in the 
published data on structural features of the polymorphs of this API.  
7.1.2. Stability Aspects of TB Polymorphs 
The relative thermodynamic relationships of TB polymorphic pairs were 
evaluated and the stability domains were elucidated in the form of a schematic energy-
temperature diagram. Form II is found to be the thermodynamically stable polymorph 
from absolute zero to ~353 K and beyond which Form IH is the stable polymorph. The 
discrepancies in the literature related to the relative stability of TB polymorphs at 
ambient conditions are highlighted and partially resolved.    
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7.1.3. Crystallization Process Development for the Isolation of Desired Form of TB 
 Using the QbD based strategy, a robust cooling crystallization process was 
developed for the isolation of desired Form (IL, IH) of TB. SMPT study of the desired 
Form (IL, IH) revealed that the primary nucleation of the stable Form II is the rate 
controlling step. MZW measurements indicated that the cooling rate has a significant 
influence on nucleation energy barrier of TB polymorphs. Using this information, a 
crystallization design space for the desired polymorph was derived and the process was 
successfully demonstrated by operating within the design space to achieve the desired 
polymorph.  
7.1.4. OPLS (PCA) and MSPM in Crystallization Operations 
 In the present work, two novel chemometric methods, OPLS (PCA) and MSPM, 
were applied for crystallization process characterization (solubility, MZW and 
polymorphic transformation measurements) and monitoring. OPLS (PCA) reduced the 
model complexity thereby enhanced the model robustness and interpretability which are 
particularly important when implementing PAT in industrial environments. On the other 
hand, MSPM is a completely data based and calibration free technique, therefore, 
significantly reduced the experimental effort and thereby speeding the process 
development. 
7.2. Scope for Future Work 
7.2.1. Raman with MSPM for Polymorph Monitoring and Control during 
Crystallization 
 Present work demonstrates the application of MSPM with Raman spectroscopy for 
monitoring polymorphic transformations, detection of nucleation and type of polymorph 
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nucleated during MZW measurements. The same idea can be extended to batch 
crystallization monitoring and control in which two dynamic PCA models can be 
separately built, one for undersaturated solution to monitor the polymorph nucleated and 
one for solid phase to monitor its polymorphic purity and can be integrated with feedback 
control strategies.     
7.2.2. Quantitative Application of Raman for Polymorph Monitoring using MSPM and 
OPLS (PCA) 
 Quantitative polymorph monitoring using Raman is proved challenging because of 
the presence of unrelated information in Raman data due to change in particle size, 
suspension density etc. We believe that MSPM analysis before building quantitative 
models may facilitate variable selection thereby enhance model performance. For 
example, in Fig. 6.4 (T2 and Q contribution plots), choosing Raman wavenumber regions 
which hold direct relationship with Forms IL and II i.e. 795–820 and 1160–1175 cm-1 
may lead to robust models. Furthermore, applying OPLS (PCA) to Raman data lead to 
simpler models and further improve the model robustness. 
7.2.3. Raman with MSPM – Can be a Powerful Tool for Monitoring Pre-nucleation    
 As discussed in chapter 6, Raman based Q contribution plots can monitor variations 
occurring in supersaturated solutions, therefore, are expected to provide valuable 
information on pre-nucleation mechanisms. An ultimate control of polymorphic 
crystallization can be achieved if one can identify these mechanisms and correlate them 
to predict the polymorph before nucleation. However, a systematic analysis is required 
before commenting on prediction of polymorphs using Q contribution plots which is part 
of our future work. 
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7.2.4. Fast Track Crystallization Process Development and Scale up  
 For any new chemical entity, application of QbD based strategy for crystallization 
process development requires a thorough screening of process parameters such as 
solvents, cooling rate etc. and their relationship with polymorphic outcome and 
transformation is desired. This results in wider design space and gives better regulatory 
flexibility to industry. To this aim, we believe that the calibration free MSPM can 
facilitate the process parameter screening and a fast track crystallization process 
development can be achieved. Furthermore, for process scale up studies, calibration 
transfer is a significant issue. We believe that OPLS (PCA) can perform better than the 
conventional PLS models and may facilitate calibration transfer in scale up studies.   
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